Document:

Exhibit 10.7

 

FORM OF LEGACY MANAGEMENT AGREEMENT1

 

THIS MANAGEMENT AGREEMENT
(the “Agreement”) is made as of [DATE] by and among [LEGACY HCR PARTNERSHIP]., a limited partnership organized under
the laws of the State of Delaware (the “Partnership”), [LEGACY GENERAL PARTNER], a limited liability company organized
under the laws of the State of Delaware (the “General Partner”), and HealthCare Royalty Management, LLC, a limited
liability company organized under the laws of the State of Delaware (the “Management Company”).

 

The parties hereto hereby agree as follows:

 

1.            Definitions.
Terms defined in the Amended and Restated Limited Partnership Agreement of the Partnership (as amended from time to time, the “Partnership
Agreement”) and not otherwise defined herein are used herein with the meanings so defined in the Partnership Agreement.

 

2.            Appointment
of the Management Company; Services. The General Partner, pursuant to Section 5.2(a) of the Partnership Agreement, hereby
appoints the Management Company to assist the General Partner in the performance of the investment advisory duties and responsibilities
of the General Partner as the general partner of the Partnership in accordance with the Partnership Agreement, which may include, without
limitation, (a) sourcing, identifying and evaluating prospective Portfolio Investments, (b) structuring and negotiating the
acquisition and disposition of Portfolio Investments on behalf of the Partnership, (c) monitoring Portfolio Investments and (d) performing
the day-to-day investment and administrative operations of the Partnership. Pursuant to Section 17-403 of the Delaware Act, such
delegation of authority to the Management Company shall not cause the Management Company to be a general partner of the Partnership and
shall not cause the General Partner to cease to be a general partner of the Partnership.

 

The Management Company shall
perform its obligations under this Agreement in a diligent and timely manner that complies with the terms and conditions set forth in
the Partnership Agreement. The Management Company may, in its reasonable discretion, subject to the Partnership Agreement, retain other
professionals, including, but not limited to, accountants, lawyers, consultants and other service providers to assist it in rendering
services to the Partnership pursuant to this Agreement.

 

3.            Status
of the Management Company. The Management Company shall for all purposes be an independent contractor and not an agent or employee
of the Partnership. The Management Company shall have no authority to act for, represent, bind or obligate the Partnership except as specifically
permitted by this Agreement and the Partnership Agreement.

 

4.            Expenses.
The Management Company shall not be required to pay (and if paid by the Management Company, the Management Company shall be
reimbursed by the Partnership for payments of) any fees and expenses related to the business of the Partnership that are described
as expenses to be borne by the Partnerships in Sections 5.3(b) and 5.3(c) of the Partnership Agreement. The Management
Company shall not be entitled to reimbursement from the Partnership for any expenses that are specified as expenses to be borne by
the General Partner or the Management Company pursuant to Section 5.3(a) of the Partnership Agreement and the Management
Company shall pay, or, if such expenses are borne by the General Partner, reimburse the General Partner for, any such
expenses.

 

 

1 Each Legacy HCR Partnership and the general partner thereof
is party to an individual management agreement with the Legacy Manager on this form with substantially the same terms.

 

    

     

    

 

5.            Payments
to be Made by the Partnership. As full compensation for the services rendered by the Management Company pursuant to the
terms of this Agreement, the Management Company shall receive the Management Fee as set forth in Section 5.2(b) of the
Partnership Agreement (either directly from the Partnership or from the General Partner, as determined by the General Partner in its
sole discretion), all such fees to be payable in accordance with the terms of the Partnership Agreement.

 

6.            Liability
and Indemnification.

 

(a)            The
Management Company, each partner, member, stockholder, officer, director, manager, trustee, employee and agent of the Management Company,
and each Affiliate of any of the foregoing shall each be a Covered Person for purposes of the Partnership Agreement. The Partnership agrees
to hold harmless and indemnify each such Covered Person as set forth in the Partnership Agreement.

 

(b)            The
provisions of this Section 6 shall survive the expiration or earlier termination of this Agreement.

 

7.            Effective
Period. This Agreement shall become effective upon its execution, and shall remain in effect until the Partnership is dissolved
pursuant to the terms of the Partnership Agreement; provided, however, that this Agreement shall terminate immediately in the event
that the General Partner is no longer [NAME OF GENERAL PARTNER] or any other Affiliate of Cowen Group or the Principal (and Cowen
Group and the Principal no longer have any direct or indirect ownership interest in, or control rights over, the General Partner).
In the event of such immediate termination, all accrued and unpaid Management Fees and expenses to which the Management Company is
entitled pursuant to the Partnership Agreement shall be paid to the Management Company either directly from the Partnership or from
the General Partner, if the Partnership has already paid such Management Fees and expenses to the General Partner. Upon termination
of this Agreement, the Management Company shall pay over to the Partnership all moneys collected and held for their account, net of
any amounts owed to the Management Company. The right of the Management Company to payment of said amounts shall be subject to the
right of offset with respect to any claim for damages (as determined by a court of competent jurisdiction) which the Partnership or
any Partner has against the Management Company.

 

8.            Amendments;
Waivers. This Agreement may be altered or amended, and any

 

provisions hereof may be waived, only upon the
written approval of the Management Company and the Partnership; provided, however, that the Partnership shall not grant any such approval
if it would cause this Agreement to be in violation of the Partnership Agreement.

 

    

2

     

    

 

9.            Notices.
All notices, requests, consents, approvals, statements and other communications hereunder shall be in writing and, if properly addressed
to the recipient, shall be deemed given if: (a) delivered personally to the recipient; (b) sent by electronic facsimile transmission
or other electronic means; (c) delivered by a reputable overnight courier service; or (d) mailed by first class mail (or if
sent from outside the United States, by airmail), postage prepaid, addressed as provided below, or to such other address as such party
may designate from time to time by written notice. Notices shall be deemed received and effective: (i) on the same day given, if
delivered personally or sent by facsimile or other electronic means before 5:00 PM New York time on any Business Day, otherwise on the
next Business Day; (ii) on the next Business Day after being sent by overnight courier service; and (iii) three (3) Business
Days after being sent by mail. The provisions of this Section 9 shall not prohibit the giving of written notice in any other manner;
provided that any such written notice shall be deemed given only when actually received.

 

If to the Management Company, to it at:

 

HealthCare Royalty Management, LLC

300 Atlantic Street, Suite 600 

Stamford, CT 06901 

Attention: Clarke B. Futch

 

If to the Partnership or the General Partner, to it at:

 

[NAME OF GENERAL PARTNER]

300 Atlantic Street, Suite 600

Stamford, CT 06901 

Attention: Clarke B. Futch

 

10.            Successors
and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs,
successors and permitted assigns. This Agreement may be assigned (as that term is defined in the Investment Advisers Act of 1940, as amended)
with the consent of (a) the General Partner and (b) the LP Advisory Committee or a Majority of the [INVESTORS IN LEGACY HCR
PARTNERSHIP].

 

11.            Headings.
The headings in this Agreement are inserted for convenience of reference only and shall not be a part of this Agreement or control or
affect the meaning hereof.

 

12.            Counterparts.
This Agreement may be executed in more than one counterpart with the same effect as if the parties executing the several counterparts
had all executed one counterpart.

 

13.            Entire
Agreement. This Agreement supersedes any and all oral or written agreements heretofore made relating to the subject matter hereof
and constitutes the entire agreement of the parties relating to the subject matter hereof.

 

14.            Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect
to any conflict or choice of law provisions that would make applicable the
domestic substantive law of any other jurisdiction.

 

    

3

     

    

  

15.            Severability.
If any one or more of the covenants, agreements, provisions or terms of this Agreement shall be held contrary to express law or against
public policy, or shall for any reason whatsoever be held invalid, then such covenants, agreements, provisions or terms shall be deemed
severable from the remainder of this Agreement and shall in no way affect the validity or enforceability of the other provisions of this
Agreement.

 

16.            No
Waiver. Notwithstanding any provision of this Agreement to the contrary, the provisions of this Agreement shall not be construed so
as to constitute a waiver of any legal right under applicable U.S. federal securities laws or any other laws whose applicability is not
permitted to be contractually waived (including without limitation the right to choose the forum, whether by arbitration or adjudication,
in which to seek resolution of disputes).

 

17.            Assignment.
Notwithstanding any provision of this Agreement to the contrary, no assignment, as that term is defined in the Investment Advisers Act
of 1940, as amended, of this Agreement shall be made by the Management Company without the written consent of the Partnership.

 

[Signature Page Follows]

 

    

     

    

 

IN WITNESS WHEREOF, the undersigned parties hereto, by their duly authorized
representatives, have executed this Agreement as of the date first above written.

 

	 	[LEGACY HCR PARTNERSHIP]
	 	 
	 	By: [GENERAL PARTNER], its general partner
	 	 
	 	 
	 	Name:
	 	Title:
	 	 
	 	[GENERAL PARTNER]
	 	 
	 	 
	 	Name:
	 	Title:
	 	 
	 	HEALTHCARE ROYALTY MANAGEMENT, LLC
	 	 
	 	 
	 	Name:
	 	Title:EXHIBIT
10.8 

 

EXECUTION VERSION

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

ASSET PURCHASE AGREEMENT

 

between

 

HARRIS FRC ACQUISITION,
LP

 

(as Purchaser)

 

and

 

HARRIS FRC CORPORATION

 

(as Seller)

 

Dated as of July 7, 2020

 

     

     

    

 

TABLE OF CONTENTS

 	 	Page
	 	 
	ARTICLE I PURCHASE AND SALE OF ASSETS;
    TRANSACTION TAXES	1
	 	 	 
	 	1.1	Transfer of Purchased Assets	1
	 	 	 
	 	1.2	Excluded Assets	2
	 	 	 
	 	1.3	Further Assurances	3
	 	 	 
	 	1.4	Transaction Taxes	3
	 	 	 
	 	1.5	Defined Terms	3
	 	 	 
	ARTICLE II LIABILITIES	3
	 	 	 
	 	2.1	Liabilities Being Assumed	3
	 	 	 
	 	2.2	Liabilities Not Being Assumed	4
	 	 	 
	ARTICLE III PURCHASE PRICE	5
	 	 	 
	 	3.1	Purchase Price	5
	 	 	 
	 	3.2	Allocation of Purchase Price	5
	 	 	 
	 	3.3	Escrow	6
	 	 	 
	ARTICLE IV CLOSING	7
	 	 	 
	 	4.1	Closing	7
	 	 	 
	ARTICLE V REPRESENTATIONS AND WARRANTIES
    OF HARRIS FRC	7
	 	 	 
	 	5.1	Organization; Good Standing; Qualification and Power	7
	 	 	 
	 	5.2	Authority; Noncontravention; Consents; Capitalization	8
	 	 	 
	 	5.3	Title to Purchased Assets; Sufficiency of Assets	9
	 	 	 
	 	5.4	Transferred Intellectual Property	9
	 	 	 
	 	5.5	Agreements, No Defaults, Etc	10
	 	 	 
	 	5.6	Litigation, Etc	11
	 	 	 
	 	5.7	Compliance	11
	 	 	 
	 	5.8	Taxes	12
	 	 	 
	 	5.9	Brokers	12
	 	 	 
	 	5.10 	Bankruptcy, Etc	12
	 	 	 
	 	5.11 .	Absence of Changes	12
	 	 	 
	 	5.12 	Foreign Corrupt Practices Act	13
	 	 	 
	 	5.13	OFAC and September 24, 2001 Executive Order	14
	 	 	 
	 	5.14 	Employees	14
	 	 	 	 
	 	5.15	No Other Representations and Warranties	15
	 	 	 	 
	 	5.16	Solvency	15

 

[*] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    -i-

     

    

 

	ARTICLE VI REPRESENTATIONS AND WARRANTIES
    OF PURCHASER	15
	 	 	 
	 	6.1	Organization; Good Standing	15
	 	 	 
	 	6.2	Authority; Noncontravention; Consents	15
	 	 	 
	 	6.3	Brokers	16
	 	 	 
	 	6.4	Litigation, Etc	16
	 	 	 
	 	6.5	Solvency	16
	 	 	 
	 	6.6	Sufficiency of Funds	17
	 	 	 
	 	6.7	Independent Investigation	17
	 	 	 
	ARTICLE VII CONDUCT AND TRANSACTIONS
    BEFORE AND AT CLOSING	17
	 	 	 
	 	7.1	Conduct of Business Prior to Closing	17
	 	 	 
	 	7.2	Access to Information	18
	 	 	 
	 	7.3	Efforts to Complete	18
	 	 	 
	 	7.4	Supplement to Schedules	18
	 	 	 
	 	7.5	Exclusivity	18
	 	 	 
	 	7.6	Government Approvals and Consents	19
	 	 	 
	 	7.7	Shareholder Meeting	19
	 	 	 
	ARTICLE VIII CLOSING CONDITIONS	19
	 	 	 
	 	8.1	Conditions to the Obligations of Both Parties	19
	 	 	 
	 	8.2	Conditions to the Obligations of Purchaser	20
	 	 	 
	 	8.3	Conditions to the Obligations of Harris FRC	21
	 	 	 
	ARTICLE IX INDEMNIFICATION	22
	 	 	 
	 	9.1	Indemnification Generally; Etc	22
	 	 	 
	 	9.2	Assertion of Claims	23
	 	 	 
	 	9.3	Notice and Defense of Third Person Claims	23
	 	 	 
	 	9.4	Survival of Representations and Warranties and Covenants	25
	 	 	 
	 	9.5	Limitations on Indemnification	26
	 	 	 
	 	9.6	[*]	27
	 	 	 
	ARTICLE X POST-CLOSING COVENANTS	27
	 	 	 
	 	10.1 	Transfer of Purchased Assets	27
	 	 	 
	 	10.2 	Publicity	27
	 	 	 
	 	10.3 	Confidentiality	28
	 	 	 
	 	10.4 	Consulting Agreement	28

 

[*] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    ii

     

    

 

	ARTICLE XI TERMINATION	28
	 	 	 
	 	11.1	Termination	28
	 	 	 
	 	11.2	Termination Procedures	29
	 	 	 
	 	11.3	Effect of Termination	29
	 	 	 
	ARTICLE XII MISCELLANEOUS PROVISIONS	29
	 	 	 
	 	12.1	No Third Party Beneficiaries	29
	 	 	 
	 	12.2	Entire Agreement	29
	 	 	 
	 	12.3	Successors and Assigns	29
	 	 	 
	 	12.4	Amendment; Waiver	30
	 	 	 
	 	12.5	Fees and Expenses	30
	 	 	 
	 	12.6	Notices	30
	 	 	 
	 	12.7	Governing Law; Jurisdiction and Venue; Waiver of Jury
    Trial	31
	 	 	 
	 	12.8	Specific Performance	33
	 	 	 
	 	12.9	Interpretation; Construction	33
	 	 	 
	 	12.10	Incorporation of Exhibits, Schedules and Annexes	34
	 	 	 
	 	12.11	Independence of Covenants and Representations and Warranties	34
	 	 	 
	 	12.12	Severability	34
	 	 	 
	 	12.13	Counterparts; Electronic Signatures	34
	 	 	 
	 	12.14	Conflict Waiver	35

 

[*] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    iii

     

    

 

ANNEX, EXHIBITS AND
SCHEDULES

 

	ANNEX	 
	 	 
	Annex I	Certain Definitions
	 	 
	EXHIBITS	 
	 	 
	Exhibit A	Bill of Sale, Assignment and Assumption Agreement
	Exhibit B	Intellectual Property Assignments
	Exhibit C	Consulting Agreement
	Exhibit D	FIRPTA Certificate
	 	 
	SCHEDULES	 
	 	 
	Schedule 1.1(f)*	Litigation Agreements
	Schedule 1.1(g)*	Assigned Trademarks
	Schedule 3.2*	Revenue by Country
	Schedule 5.1	Foreign Qualifications
	Schedule 5.2(c)	Harris FRC Authority; Noncontravention; Consents
	Schedule 5.2(d)*	Capitalization
	Schedule 5.4(a)*	Intellectual Property Matters
	Schedule 5.4(b)	Intellectual Property Protections
	Schedule 5.5(a)	Agreements
	Schedule 5.5(b)*	No Defaults
	Schedule 5.5(c)*	Royalties
	Schedule 5.5(d)*	Correspondence, Reports, Notices, Etc.
	Schedule 5.5(e)*	Royalties, Etc., Received and Paid
	Schedule 5.6*	Litigation, Etc.
	Schedule 5.8	Taxes
	Schedule 5.9	Brokers
	Schedule 5.11	Absence of Changes
	Schedule 5.14(a)*	Business Employees
	Schedule 5.14(b)	Employee Benefit Plans
	Schedule 6.2	Purchaser Authority; Noncontravention; Consents
	*Schedules have been omitted in reliance
    upon Item 601(a)(5) of Regulation S-K.

 

[*] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    iv

     

    

 

Index of Defined Terms

 

The
following capitalized terms, which may be used in more than one Section or other location of this Agreement, are defined in the following
Sections or other locations:

 

	TERM	LOCATION
	 	 
	Affiliate	Annex I
	Agreement	12.9(a)
	Allocation	3.2(a)
	Amendment Agreement	1.1(e)
	Another Transaction	Annex I
	Assigned Contracts	1.1(f)
	Assigned Trademarks	1.1(g)
	Assumed Liabilities	2.1
	Back Royalties	1.1(j)
	Base Purchase Price	3.1(a)
	Business	Annex I
	Business Day	Annex I
	Business Employees	5.14(a)
	Cap	9.5(a)(ii)
	Cash Payment	3.1(a)
	CLM	12.14
	Closing	4.1
	Closing Date	4.1
	Code	Annex I
	Confidentiality Agreement	10.3
	Confidential Information	10.3
	Contemplated Transactions	Annex I
	Contract	Annex I
	Control	Annex I
	Development Agreement	1.1(b)
	Employee Benefit Plan	Annex I
	Encumbrances	Annex I
	Environmental, Health and Safety Laws	Annex I
	ERISA	Annex I
	ERISA Affiliate	Annex I
	Escrow Amount	Annex I
	Escrow Agent	Annex I
	Escrow Agreement	Annex I
	Escrow Income	3.3(b)
	Excluded Assets	1.2
	Excluded Liabilities	2.2
	Expense Reimbursement Amount	Annex I
	FDA	Annex I
	Fraud	Annex I

 

[*] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    v

     

    

 

	Final Allocation	3.2(a)
	Fundamental Documents	Annex I
	Fundamental Representations 	Annex I
	GAAP	Annex I
	Governmental Entity	Annex I
	Harris FRC	Caption
	Harris FRC Indemnified Persons	Annex I
	Harris FRC Indemnifying Persons	Annex I
	Harris FRC Losses	Annex I
	Harris-Paid Q1 RCT Royalties	2.2(b)
	Harris-Received Q1 UCB Royalties	1.2
	Hazardous Materials	Annex I
	HSR Act	Annex I
	Indemnification Claim	3.3(b)(i)
	Indemnified Persons	Annex I
	Indemnifying Persons	Annex I
	Independent Accounting Firm	3.2(a)
	Intellectual Property Rights	Annex I
	Know-How	Annex I
	Knowledge	Annex I
	Law	Annex I
	Liability	Annex I
	Litigation Agreements	1.1(f)
	Litigation Expense	Annex I
	Long-Stop Date	11.1(b)
	Losses	Annex I
	Material Adverse Change	Annex I
	Orders	Annex I
	OFAC	5.13
	Parties	Caption
	Patents	Annex I
	Permits	Annex I
	Permitted Encumbrances	Annex I
	Person	Annex I
	Pre-Closing Period	7.1
	Proceedings	Annex I
	Product	Preamble
	Purchase Price	3.1(a)
	Purchased Assets	1.1
	Purchased Claims	1.1(j)
	Purchaser	Caption
	Purchaser Indemnified Persons	Annex I
	Purchaser Indemnifying Persons	Annex I
	Purchaser Losses	Annex I
	Qualifying Unilateral Settlement	9.3(f)
	Q1 Royalty Adjustment	3.1(b)

 

[*] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    -vi-

     

    

 

	RCT	1.1(a)
	RCT License Agreement	1.1(a)
	Related Documents	8.2(d)
	Release Date	3.3(b)(iii)
	Representatives	Annex I
	Requisite Shareholder Approval	Annex I
	Schedule Supplement	7.4
	Shareholder Claims	Annex I
	Shareholder/Purchaser Claim	9.3(b)
	Survival Date	9.4(c)
	Tax or Taxes	Annex I
	Tax Return	Annex I
	Taxing Authority	Annex I
	Third Person Claim	9.3
	Threshold	9.5(a)(i)
	Trademark Agreement	1.1(d)
	Trademarks	Annex I
	Trade Names	Annex I
	Transaction Taxes	1.4
	Transferred Intellectual Property	1.1(g)
	UCB	1.1(b)
	UCB License Agreement	1.1(c)
	UCBSA	1.1(b)

 

[*]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    -vii-

     

    

 

 

ASSET PURCHASE AGREEMENT, dated as of
July 7, 2020, between Harris FRC Acquisition, LP, a Delaware limited partnership (“Purchaser”), and HARRIS FRC CORPORATION,
a New Jersey corporation (“Harris FRC,” and, together with Purchaser, the “Parties”).

 

PREAMBLE

 

Harris FRC possesses
intellectual property and other rights relating to the chemical compound called lacosamide, which is commercially available under the
trade name Vimpat (the “Product”), and is engaged in the business of collecting and paying royalties related to those
rights and maintaining and enforcing related Contracts.

 

Purchaser wants to
acquire from Harris FRC, and Harris FRC wants to sell to Purchaser, those intellectual property rights to the Product and certain related
Contracts and assets on the terms and conditions set out in this Agreement.

 

Two shareholders
of Harris FRC, Mary Ellen Harris and the Marital Trust under the Robert H. Harris Living Trust, have entered into a Support Agreement
with Purchaser, dated as of the date of this Agreement, in which each of them agreed to, among other things, vote all of their shares
of Harris FRC in favor of the transactions contemplated by this Agreement.

 

ACCORDINGLY, Harris FRC and Purchaser hereby agree
as follows:

 

ARTICLE I

 

PURCHASE AND SALE OF
ASSETS; TRANSACTION TAXES

 

1.1          Transfer
of Purchased Assets.

 

On
the terms and subject to the conditions contained in this Agreement, at the Closing, Harris FRC shall sell, transfer, convey and assign
to Purchaser, free and clear of all Encumbrances, and Purchaser shall purchase and acquire from Harris FRC, all of Harris FRC’s
right, title and interest in, to and under all of the following Contracts, assets, properties, interests in properties and rights, whether
tangible or intangible and whether real, personal or mixed, as the same exist immediately before the Closing, but excluding the Excluded
Assets (collectively, the “Purchased Assets”):

 

(a)       the
Second Amended and Restated License Agreement, dated December 17, 2010 (as amended, the “RCT License Agreement”),
between Harris FRC and Research Corporation Technologies, Inc. (“RCT”);

 

(b)       the
Development Agreement, dated December 20, 1999 (as amended, the “Development Agreement”), between Harris FRC, UCB
Pharma GmbH (“UCB”) and UCB, S.A. (“UCBSA”);

 

(c)      
the License Agreement, dated December 20, 1999 (as amended, the “UCB License Agreement”), between Harris FRC, UCB
and UCBSA, including the right to receive royalty payments from UCB under the UCB License Agreement in respect of sales of the Product
for the period beginning on April 1, 2020;

 

[*] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities
and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    1 

     

    

 

(d)       the
Trademark License Agreement, dated December 20, 1999 (as amended, the “Trademark Agreement”), between Harris FRC,
UCB and UCBSA, including the right to receive royalty payments from UCB under the Trademark License Agreement in respect of sales of
the Product for the period beginning on April 1, 2020;

 

(e)       the
Amendment Agreement to the Trademark License Agreement, dated July 15, 2019 (as amended, the “Amendment Agreement”),
between Harris FRC, UCBSA and UCB Biopharma SPRL, including the right to receive royalty payments from UCB under the Amendment Agreement
in respect of sales of the Product for the period beginning on April 1, 2020;

 

(f)        all
Contracts set out on Schedule 1.1(f) (the “Litigation Agreements” and, together with the RCT License Agreement,
the Development Agreement, the UCB License Agreement, the Trademark License Agreement and the Amendment Agreement, the “Assigned
Contracts”);

 

(g)       all
rights in and to the Trademarks described in Schedule 1.1(g) (the “Assigned Trademarks”) and all Know-How related
to the Product or the Business (collectively, the “Transferred Intellectual Property”);

 

(h)       all
books, records and files related primarily to the Product or the Assigned Contracts, or portion thereof, in the control of Harris FRC,
including (i) all data in all databases for all clinical and pre-clinical studies for all drug trials undertaken in connection with the
Product, (ii) all Transferred Intellectual Property files, file histories and other technical documents and correspondence, and (iii)
all business information, tangible or intangible, to the extent relating to the Product or the Business;

 

(i)        all
goodwill of Harris FRC related to the Assigned Trademarks or other Purchased Assets; and

 

(j)        all
of Harris FRC’s rights, claims, counterclaims, credits, causes of action or rights of set-off against third Persons that relate
primarily to the Purchased Assets (“Purchased Claims”), liquidated or unliquidated, including (i) claims for past
infringement or misappropriation of the Transferred Intellectual Property and (ii) claims against UCB related to the calculation of royalty
payments for any period, including past royalty payments, under the UCB License Agreement (“Back Royalties”).

 

1.2          Excluded
Assets.

  

Purchaser
shall not purchase or acquire from Harris FRC, and Harris FRC shall not sell, transfer, convey or assign to Purchaser, any right, title
or interest in, to and under any Contracts, assets, properties, interests in properties or rights (whether real, personal or mixed, tangible
or intangible) other than the Purchased Assets, including any royalties or other amounts actually received by Harris FRC before the Closing
under any Assigned Contract in respect of sales of the Product for the period ending March 31, 2020 (“Harris-Received Q1 UCB
Royalties”), but excluding Back Royalties (collectively, the “Excluded Assets”).

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 2 -

     

    

 

1.3       Further
Assurances.

 

Harris FRC shall, from time
to time after the Closing, upon the request of Purchaser, do, execute, acknowledge and deliver, and cause to be done, executed, acknowledged
or delivered, all such further acts, documents, instruments, deeds, assignments, transfers, conveyances or assurances as Purchaser may
reasonably request to carry out the provisions of this Agreement and to complete the Contemplated Transactions, including to transfer,
assign, convey and grant to, and confirm ownership in, Purchaser, or to aid and assist in the reducing to possession by Purchaser of
the Purchased Assets, or to vest in Purchaser good and marketable title to the Purchased Assets. If any of the Purchased Assets are not
by their respective terms assignable, Harris FRC shall use its reasonable best efforts to obtain, or cause to be obtained, prior to the
Closing, any written consents necessary to convey to Purchaser the benefit thereof. To the extent that any such consents cannot be obtained
prior to the Closing, the assignment of the affected Purchased Assets shall not occur at Closing but shall be deferred until Harris FRC
and Purchaser have obtained the required consent. Harris FRC will continue to use its reasonable best efforts after the Closing to take
such actions as may be possible without violation or breach of any such non-assignable Purchased Assets to effectively provide Purchaser
with the economic benefits of those non-assignable Purchased Assets. Once any such consent has been obtained, Harris FRC shall assign
the Purchased Asset(s) to which that consent relates for no additional consideration.

 

1.4       Transaction
Taxes.

 

Purchaser shall pay any sales,
use, transfer, value added, license, documentary, recording, stamp or similar Taxes imposed (other than income or similar Taxes) on the
sale, transfer or conveyance of the Purchased Assets to Purchaser (the “Transaction Taxes”). Harris FRC and Purchaser
shall coordinate with each other on the filing of any forms required in connection with any Transaction Taxes. Harris FRC shall cooperate
with Purchaser to minimize the amount of any Transaction Taxes imposed in connection with the sale of the Purchased Assets to Purchaser.

 

1.5       Defined
Terms.

 

Certain capitalized terms used in this Agreement
are defined in Annex I attached hereto.

 

ARTICLE II

 

LIABILITIES

 

2.1       Liabilities
Being Assumed.

 

On the terms and subject
to the conditions contained in this Agreement, effective as of the Closing, and from and after the Closing, except as otherwise set out
in this Section 2.1, Purchaser shall pay or assume, perform and discharge when due, the following Liabilities of Harris FRC (collectively,
the “Assumed Liabilities”).

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 3 -

     

    

 

(a)       all
Liabilities relating to or arising out of the ownership of the Transferred Intellectual Property accruing after the Closing Date;

 

(b)       all
Liabilities accruing after the Closing Date under each Assigned Contract in accordance with the provisions of that Assigned Contract,
and all Liabilities (regardless of when accruing) to pay royalties to RCT under the RCT License Agreement in accordance with the provisions
of the RCT License Agreement in respect of sales of the Product for any period beginning on or after April 1, 2020;

 

(c)      
any Liabilities, including royalty payments that may become due to RCT under the RCT License Agreement, arising in respect of any Purchased
Claims;

 

(d)      
any Liabilities accruing after the Closing Date arising out of any claim, irrespective of the legal theory asserted, related to (i) the
Assigned Contracts or (ii) the ownership, licensing, possession or use by or on behalf of Purchaser of the Purchased Assets from and
after the Closing, including claims for infringement of Intellectual Property Rights; and

 

(e)      
any Liabilities accruing after the Closing Date related to Taxes payable in connection with the ownership, licensing, possession, enjoyment
or use of the Purchased Assets by Purchaser after the Closing.

 

2.2       Liabilities
Not Being Assumed.

 

Purchaser is not assuming
and shall not be obligated to pay, perform and discharge when due or satisfy, and Harris FRC shall retain and remain responsible for,
any Liabilities of Harris FRC other than the Assumed Liabilities (collectively, the “Excluded Liabilities”), including
the following:

 

(a)       any
Liabilities relating to or arising out of the ownership of the Transferred Intellectual Property accruing on or before the Closing Date;

 

(b)     
  any Liabilities accruing under any Assigned Contract on or before the Closing Date, including all royalties and other amounts actually
paid by Harris FRC to RCT before the Closing under the RCT License Agreement in respect of sales of the Product for the period beginning
on January 1, 2020 and ending on March 31, 2020 (“Harris-Paid Q1 RCT Royalties”) but excluding all Liabilities
to pay royalties to RCT under the RCT License Agreement in respect of sales of the Product for any period beginning on or after April
1, 2020 or in respect of Back Royalties;

 

(c)      
any Liabilities arising out of any claim, irrespective of the legal theory asserted, related to (i) the Assigned Contracts or (ii) the
ownership, licensing, possession or use of the Purchased Assets by or on behalf of Harris FRC, including claims for infringement of Intellectual
Property Rights, in each case, on or before the Closing Date, but excluding all Liabilities to pay royalties to RCT under the
RCT License Agreement in respect of sales of the Product for any period beginning on or after April 1, 2020 with respect of Back Royalties;

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 4 -

     

    

 

(d)       (i)
all Taxes of Harris FRC and (ii) all Taxes of any other Person for which Harris FRC may be liable (A) as a result of being a member of
any affiliated, consolidated, combined, unitary or similar Tax group at any time prior to the Closing or (B) as a transferee or successor,
by operation of Law or otherwise, as a result of a merger, reorganization or other transaction occurring prior to the Closing or any
Contract entered into prior to the Closing. For the avoidance of doubt, Excluded Liabilities shall include any Tax for which Purchaser
may become liable as a result of the Parties’ failure to comply with any bulk sales, successor or transferee liability or similar
provisions relating to Taxes in connection with the purchase of the Purchased Assets;

 

(e)       any
Liabilities with respect to any Employee Benefit Plan that Harris FRC or any Affiliate of Harris FRC maintains, contributes to, has an
obligation to contribute to or otherwise has any Liability with respect thereto;

 

(f)       any
Liabilities relating to or arising out of the employment or service with Harris FRC, or termination of employment or service with Harris
FRC, of any employee, former employee, director, officer, consultant or advisor of the Harris FRC;

 

		(g)	any Liabilities relating to Excluded Assets;
                                            and

 

		(h)	any Liabilities arising out of, related
                                            to or in connection with any Shareholder Claims.

 

ARTICLE III

 

PURCHASE PRICE

 

3.1           Purchase
Price.

 

(a)      The
purchase price for the Purchased Assets is [*], less the Q1 Royalty Adjustment (the “Base Purchase Price”),
plus the assumption by Purchaser of the Assumed Liabilities (collectively, the “Purchase Price”). At
the Closing, Purchaser shall pay to Harris FRC an amount (the “Cash Payment”) equal to (i) the Base Purchase Price,
less (ii) the Escrow Amount, less (iii) the Expense Reimbursement Amount, by wire transfer of immediately
available United States dollars to an account designated by Harris FRC.

 

(b)      The
 “Q1 Royalty Adjustment” means an amount equal to the Harris-Received Q1 UCB Royalties less the Harris-Paid
Q1 RCT Royalties.

 

3.2          Allocation
of Purchase Price.

 

(a)      The
Purchase Price (and other items treated as consideration for the Purchased Assets for U.S. federal income Tax purposes) shall be allocated
in accordance with the requirements of Section 1060 of the Code and the Treasury Regulations promulgated thereunder (the “Allocation”).
Purchaser shall prepare and deliver a draft purchase price allocation to Harris FRC within 180 days after the Closing Date, which shall
be subject to the consent of Harris FRC and which shall, to the extent relevant and consistent with applicable Law, be consistent with
the revenue by country information attached hereto as Schedule 3.2. The Parties shall cooperate to resolve any disagreements regarding
the Allocation within 60 days after delivery of that draft. Any disagreement the Parties are unable to resolve within such 60-day period,
shall be resolved by PricewaterhouseCoopers (the “Independent Accounting Firm”). The Allocation, as finalized by agreement
of the Parties or by the Independent Accounting Firm, is called the “Final Allocation.” Unless otherwise required
by Law, none of the Parties or any of their Affiliates shall take any position inconsistent with the Final Allocation on any Tax Return
(including IRS Form 8594) or for any other U.S. federal, state, local or non-U.S. income Tax purpose.

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 5 -

     

    

 

(b)      All
indemnification payments made under Article IX shall be treated by the Parties and their respective Affiliates as an adjustment
to the Purchase Price for all applicable income tax purposes, unless otherwise required by applicable Law.

 

(c)     
Purchaser shall be entitled to deduct and withhold from the Purchase Price or any other amounts payable to Harris FRC hereunder, any
amounts required to be deducted and withheld under the Code or any provisions of applicable U.S. state, local or non-U.S. Tax Law. Any
amounts so deducted and withheld shall be treated for all purposes of this Agreement as having been paid to Harris FRC.

 

3.3          Escrow.

 

(a)      At
the Closing, Purchaser shall deposit the Escrow Amount with the Escrow Agent to be held in accordance with the terms of this Agreement
and the Escrow Agreement. The Escrow Amount shall be available to satisfy Harris FRC’s indemnification obligations pursuant to
and in accordance with the provisions of Article IX and this Section 3.3.

 

(b)      The
interest and proceeds earned on the Escrow Amount are called the “Escrow Income,” and shall accrue to and become part
of the Escrow Amount. The Escrow Agent shall pay the Escrow Amount as follows:

 

(i)
      from time to time, to the Purchaser upon joint instructions of the Purchaser and Harris FRC, for indemnification
under Article IX (each claim by a Purchaser Indemnified Person for indemnification, an “Indemnification Claim”);

 

(ii)
      annually, within 60 days after the end of each calendar year, to Harris FRC, an amount equal to 40% of
the Escrow Income that constitutes taxable income for United States Federal income Tax purposes for that calendar year;

 

(iii)     
on the date that is 12 months after the Closing Date (the “Release Date”), to Harris FRC, an amount, if greater than
zero, equal to any remaining balance of the Escrow Amount minus the amount of any Indemnification Claim that has been asserted
by the Purchaser but not satisfied; and

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 6 -

     

    

 

(iv)      from time to
time after the Release Date, to the Purchaser or Harris FRC as any Indemnification Claims that were unsatisfied on the Release Date are
resolved.

 

(c)      The
Escrow Income that constitutes taxable income for United States federal income and applicable state, local and non-U.S. income Tax purposes
and any losses on the Escrow Amount shall be allocated to Harris FRC.

 

(d)     
Harris FRC and the Purchaser shall provide instructions to the Escrow Agent to implement the provisions of this Section 3.3, including
instructions (i) to pay to a Purchaser Indemnified Person the amount of any Indemnification Claim within 5 days after the claim is accepted,
no longer disputed, settled or resolved and (ii) to pay to Harris FRC within 5 days after the Release Date the remaining balance of the
Escrow Amount minus the amount of any Indemnification Claim that has been asserted by the Purchaser but not satisfied.

 

(e)      Any
payments from the Escrow Amount to the Purchaser under this Section 3.3 shall be treated by the Parties and their respective Affiliates
as an adjustment to the Purchase Price for all applicable income Tax purposes, unless otherwise required by applicable Law.

 

ARTICLE IV

 

CLOSING

 

4.1       Closing.

 

The closing of the sale of
the Purchased Assets to Purchaser, and the Contemplated Transactions (the “Closing”), shall take place remotely on
a date to be specified by the Parties, which date shall be no later than four Business Days after the date on which all closing conditions
set out in Article VIII have been satisfied or waived (other than those conditions that by their nature will be satisfied at the
Closing, but subject to their satisfaction), or on such other date to which Harris FRC and Purchaser mutually agree (the “Closing
Date”). The Closing will be deemed to occur as of midnight at the end of the Closing Date.

 

ARTICLE V

 

REPRESENTATIONS AND WARRANTIES
OF HARRIS FRC

 

Harris FRC hereby represents
and warrants to Purchaser as of the date of this Agreement and as of the Closing Date as follows:

 

5.1       Organization;
Good Standing; Qualification and Power.

 

Harris
FRC is a corporation duly organized, validly existing and in good standing under the Laws of the State of New Jersey and has all requisite
corporate power and authority to own the Purchased Assets and to carry on the Business as now being conducted. Harris FRC is duly licensed
or qualified to transact business and in good standing to do business in each jurisdiction in which the nature of its operations related
to the Purchased Assets, including its ownership of any of the Purchased Assets, makes that licensing or qualification necessary, except
to the extent that its failure to be so licensed or qualified would not reasonably be expected to result in a Material Adverse Change.
Each jurisdiction in which Harris FRC is licensed or qualified to transact business is set out on Schedule 5.1.

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 7 -

     

    

 

5.2          Authority;
Noncontravention; Consents; Capitalization.

 

(a)     
Harris FRC has all requisite corporate power and authority to enter into this Agreement and each Related Document to which it is a party,
to perform its obligations hereunder and thereunder and to complete the Contemplated Transactions. Subject to receipt of the Requisite
Shareholder Approval, Harris FRC has complied with and has fully satisfied all requirements under applicable Law, including the New Jersey
Business Corporation Act, with respect to the approval of and authorization to enter into this Agreement and the Related Documents and
to complete the Contemplated Transactions. The execution and delivery by Harris FRC of this Agreement and each Related Document to which
Harris FRC is a party, and, subject to receipt of the Requisite Shareholder Approval, the performance by Harris FRC of its obligations
hereunder and thereunder, have been duly and validly authorized by all necessary action on the part of Harris FRC. This Agreement and
each Related Document to which Harris FRC is a party have been duly and validly executed and delivered by Harris FRC and, assuming due
authorization, execution and delivery by Purchaser, are the valid and binding obligations of Harris FRC, enforceable against Harris FRC
in accordance with their terms.

 

(b)      Neither
the execution and delivery by Harris FRC of this Agreement and each Related Document to which Harris FRC is a party, nor the performance
by Harris FRC of any of its obligations hereunder and thereunder, nor the completion of the Contemplated Transactions, with or without
the giving of notice or lapse of time or both, (i) conflicts with, violates, constitutes a breach or default under, gives rise to a right
of termination, amendment, cancellation, acceleration of any material obligation contained in or imposition of additional obligations
or the loss of any material benefit under, or results in the creation of any Encumbrance upon any of the Purchased Assets under, any
term, condition or provision of (A) Harris FRC’s Fundamental Documents or (B) any Assigned Contract, or (ii) violates in any material
respect any Laws applicable to Harris FRC or any of the Purchased Assets.

 

(c)      Except
as set out on Schedule 5.2(c), no (i) consent, (ii) approval, (iii) Order or authorization of, (iv) registration, declaration
or filing with, or (v) notification to any Governmental Entity or any other Person is required in connection with the execution and delivery
by Harris FRC of this Agreement or the Related Documents to which Harris FRC is a party, the performance by it of its obligations hereunder
or thereunder or the completion of the Contemplated Transactions. The approval of Harris FRC’s board of directors, which has already
been obtained, and the affirmative vote of a majority of the shares of Harris FRC is all that is required under the New Jersey Business
Corporation Act to approve the Contemplated Transaction.

 

(d)      Schedule
5.2(d) sets out the capitalization of Harris FRC, and the Persons listed on that schedule are the record owners of those shares,
and all of those shares were duly authorized and are validly issued, fully-paid and non-assessable. Other than the equity interests set
out on Schedule 5.2(d), there are no equity interests of Harris FRC issued or outstanding. There are no outstanding or authorized
options, warrants, convertible securities or other rights, agreements, arrangements or commitments of any character relating to the capitalization
of Harris FRC.

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 8 -

     

    

 

5.3           Title
to Purchased Assets; Sufficiency of Assets.

 

(a)      Harris
FRC has good, valid and marketable title to all Purchased Assets free and clear of any Encumbrances, other than Permitted Encumbrances.
There are no assets, properties, interests in assets or properties or rights owned or held by any Person other than Harris FRC, including
any Affiliate of Harris FRC, that would be Purchased Assets if owned or held by Harris FRC, and no Person other than Harris FRC has any
right, title or interest in or to any of the Purchased Assets.

 

(b)      The
Purchased Assets are sufficient, and constitute all of the assets necessary to operate the Business and receive all of the royalty payments
and similar economic benefits of the Business, following the Closing in the same manner and to the same extent as Harris FRC received
them before Closing, except that the administrative, office and support functions of Harris FRC, including those required to review,
determine, administer and enforce the rights and obligations of the Business, are excluded from the scope of the Contemplated Transactions,
and, accordingly, Purchaser would have to provide or obtain its own substitutes for those functions in order to operate the Business
after the Closing in substantially the same manner as Harris FRC operated the Business before the Closing.

 

		5.4	Transferred Intellectual
                                            Property.

 

		(a)	Except in each case as set out on Schedule
                                            5.4(a):

 

(i)      Harris
FRC owns, has the exclusive right to use, sell, license and dispose of, and has the exclusive right to bring actions for the infringement
of, the Transferred Intellectual Property;

 

(ii)     
there are no royalties, honoraria, fees or other amounts payable to any Person or claimed by any Person by reason of the ownership, use,
license, sale or disposition of the Transferred Intellectual Property;

 

(iii)     
nothing has been done or omitted to be done by Harris FRC or, to the Knowledge of Harris FRC, done by any other Person, that would adversely
affect the validity, enforceability or subsistence of any item included in the Transferred Intellectual Property. Harris FRC has enforced
a policy requiring each and every employee and contractor to execute proprietary information and confidentiality agreements, and each
current and former employee and contractor of Harris FRC that has been involved in the development of the Transferred Intellectual Property
has executed such an agreement. To the extent that any employee or third Person has developed any Transferred Intellectual Property for
Harris FRC, Harris FRC has a written agreement with that employee or third Person with respect thereto and thereby has obtained ownership
of, and is the exclusive owner of, all rights in that Transferred Intellectual Property;

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 9 -

     

    

 

(iv)     
to the Knowledge of Harris FRC, no Transferred Intellectual Property infringes any Intellectual Property Rights of any Person;

 

(v)     
Harris FRC has not received from any Person in the past 5 years any written notice, charge, complaint, claim or assertion that the Transferred
Intellectual Property or its activities or contemplated activities with respect to the Transferred Intellectual Property infringe or
would infringe any Intellectual Property Rights of any Person, and no such claim is impliedly threatened by an offer to license from
another Person under a claim of use;

 

(vi)      Harris
FRC has not sent to any Person in the past 5 years, or otherwise communicated to any Person, any written notice, charge, complaint, claim
or other assertion of any present, impending or threatened infringement by or misappropriation of, or other conflict with, any Transferred
Intellectual Property by that other Person;

 

(vii)     
Harris FRC has not licensed any of the Transferred Intellectual Property to any third Person;

 

(viii)      other
than the Transferred Intellectual Property, Harris FRC does not own or license any Intellectual Property Rights related to the Product;
and

 

(ix)      the
Transferred Intellectual Property constitutes all of the Intellectual Property Rights necessary to receive all of the royalty payments
and other economic benefits to which Harris FRC is entitled under the Assigned Contracts.

 

(b)      Schedule
5.4(b) contains a true and complete list of all pending applications, maintenance and renewal filings and other formal actions made
or taken by or on behalf of Harris FRC pursuant to any Laws to perfect or protect its interest in the Transferred Intellectual Property,
including all trademarks, service marks, copyrights and applications for each of the foregoing.

 

5.5          Agreements,
No Defaults, Etc.

 

(a)     
Except as set out on Schedule 5.5 and other than the Assigned Contracts, Harris FRC is not a party to any material Contract
related to the Product or the Purchased Assets, including any Contract related to the Transferred Intellectual Property and any Contract
concerning royalties or other economic benefits or obligations related to the Product.

 

(b)      Except
as set out on Schedule 5.5, all Assigned Contracts are in full force and effect, constitute legal, valid and binding obligations
of Harris FRC and, to the Knowledge of Harris FRC, the other parties thereto, and are enforceable in accordance with their respective
terms against Harris FRC, and to the Knowledge of Harris FRC, each other party thereto. Except as set out on Schedule 5.5, Harris
FRC has in all material respects performed all of the obligations required to be performed by it under each such Assigned Contract, and
there exists no violation, breach or default by Harris FRC or, to the Knowledge of Harris FRC, any other party, or any event that upon
the giving of notice or the passage of time, or both, would give rise to a claim of a violation, breach or default by Harris FRC or,
to the Knowledge of Harris FRC, any other party, under any of their respective obligations thereunder, in any material respect. Harris
FRC has made available to Purchaser correct and complete copies of all Assigned Contracts.

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 10 -

     

    

 

(c)
      To the Knowledge of Harris FRC, except for the Back Royalties and amounts payable to RCT in connection
with the Back Royalties, there are no unpaid royalties or other amounts, in excess of [*], due under any of the Assigned Contracts,
nor, with respect to RCT, are there any open discussions or amounts in dispute with respect to amounts payable to RCT, except as set
out on Schedule 5.5(c). The Assigned Contracts constitute the only Contracts necessary for Harris FRC (or following the Closing,
Purchaser) to realize the full and complete benefit, economic or otherwise, of the Business as currently conducted (excluding, for the
avoidance of doubt, any contracts that relate to administrative, office and support functions of Harris FRC that are excluded from the
scope of the Contemplated Transactions). Harris FRC is entitled to receive all royalty and other payments pursuant to the explicit terms
and conditions set forth in the Assigned Contracts. Except as set out on Schedule 5.5(c), neither Harris FRC nor any of its Affiliates
have, in each case, excluding amounts of [*] or less: (i) forgiven, released, delayed, postponed or compromised any payment under any
Assigned Contract; (ii) waived, amended, cancelled or terminated any material rights under any Assigned Contract; (iii) exercised any
right of rescission, offset, counterclaim or defense under any Assigned Contract; (iv) sold, leased, pledged, licensed, transferred or
assigned all or any portion of any Assigned Contract or any benefits, economic or otherwise, thereunder; or (iii) received any advance
payments under any Assigned Contract.

 

(d)      Except
as set out on Schedule 5.5(d), Harris FRC has provided Purchaser with copies of all material correspondence, reports (including
royalty reports) notices or other material information related to the Purchased Assets and the Business, in each case dated on or after
January 1, 2016, including any correspondence sent to Harris FRC from any Governmental Entity or any counterparty to an Assigned Contract
relating to compliance matters.

 

(e)      Schedule
5.5(e) sets forth a true and complete list of (i) royalties and/or other payments received by Harris FRC from UCB by payment date
since January 1, 2018 and (ii) each payment made by Harris FRC to RCT since January 1, 2018.

 

5.6         Litigation,
Etc.

 

Except as set out on Schedule
5.6, there are no (a) Proceedings pending or, to the Knowledge of Harris FRC, threatened against Harris FRC or the Purchased Assets,
whether at law or in equity, or before or by any Governmental Entity or arbitrator or (b) Orders of any Governmental Entity or arbitrator
naming Harris FRC or the Purchased Assets, including any Proceeding challenging, enjoining or seeking to prevent the performance of this
Agreement or the completion of the Contemplated Transactions.

 

5.7       Compliance.

 

The Business of Harris FRC
is not being, and in the last three years has not been, conducted in violation in any material respect of any Law or Order applicable
in any jurisdiction in which Harris FRC operates, including Environmental, Health and Safety Laws. To the Knowledge of Harris FRC, no
investigation or review by any Governmental Entity with respect to the Business or the Purchased Assets is pending or threatened, nor
has any Governmental Entity notified Harris FRC of its intention to conduct the same.

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 11 -

     

    

 

5.8       Taxes.

 

Except as set out on Schedule
5.8, (a) all material Tax Returns required to have been filed by or on behalf of Harris FRC have been timely (taking into account
applicable extensions) filed with the applicable Taxing Authorities, and each of those Tax Returns is true, correct and complete in all
material respects, (b) all Taxes due and payable by Harris FRC (including in its capacity as a withholding agent), regardless of whether
or not those Taxes are shown as due on those Tax Returns, have been paid and (c) no Tax Return filed by Harris FRC with respect to the
Purchased Assets is currently being examined (or subject to any pending or threatened examination) by any Taxing Authority, and there
are no outstanding agreements or waivers extending the statute of limitations applicable to any such Tax Return. Harris FRC is a “United
States person” within the meaning of Section 7701(a)(30) of the Code. There are no liens for Taxes on the Purchased Assets other
than Permitted Encumbrances. Except as set out on Schedule 5.8, none of the amounts payable to Harris FRC pursuant to any Assigned
Contract has been subject to any withholding Tax or has been paid net of any withholding Tax, and no such Tax has been asserted to be
due by any Taxing Authority. Harris FRC has not been subject to Tax in any non-U.S. jurisdiction as a result of owning or licensing any
of the Purchased Assets, and no non-U.S. jurisdiction has asserted otherwise.

 

5.9       Brokers.

 

Except as set out on Schedule
5.9, neither Harris FRC nor any of its officers, directors, equity owners or employees nor any other Person acting on its or their
behalf has employed or engaged any broker or finder, or incurred any Liability for any brokerage fees, commissions, finders’ fees
or similar fees, in connection with the Contemplated Transactions. To the extent that Harris FRC has incurred any Liability for any brokerage
fees, commissions, finder’s fees or similar fees in connection with Contemplated Transactions, Harris FRC will be solely responsible
for the payment of those commissions or fees.

 

5.10       Bankruptcy,
Etc.

 

Harris FRC is not involved
in any Proceeding by or against it as a debtor before any Governmental Entity under Title 11 of the United States Code or any other insolvency
or debtors’ relief Law, whether state, federal or foreign, or for the appointment of a trustee, receiver, liquidator, assignee,
sequestrator or other similar official for any part of Harris FRC’s property.

 

5.11       Absence
of Changes.

 

Since January 1, 2020, there
has not been any change, event or development which, individually or together with other such events, could reasonably be expected to
have a Material Adverse Change on Harris FRC, the Purchased Assets or the Business. Without limiting the foregoing, except as set out
on Schedule 5.11, since January 1, 2020, Harris FRC has operated the Business and maintained the Purchased Assets in the ordinary
course of business consistent with past practice, and there has not occurred:

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    - 12 -

     

    

 

  

(a)        any
write-off or write-down, or any determination to write off or write down, any of the Purchased Assets;

 

(b)        any
incurrence of an Encumbrance (other than a Permitted Encumbrance) on any Purchased Asset;

 

(c)        any
(i) amendment of the certificate of incorporation or bylaws of Harris FRC or (ii) recapitalization, reorganization, liquidation or dissolution
of Harris FRC;

 

(d)        any
material amendment, modification, termination (partial or complete) or granting of a waiver under or giving any consent with respect
to any Assigned Contract;

 

(e)        any
transaction, relating to the Product or the Purchased Assets, between Harris FRC, on the one hand, and any officer, director, shareholder
or Affiliate of Harris FRC, on the other hand;

 

(f)        to
Harris FRC’s Knowledge, except as set forth in UCB’s report of sales activities and resulting royalty obligations for Q1
2020 regarding Vimpat, dated May 11, 2020, any transaction involving or development affecting the Purchased Assets outside of the ordinary
course of business consistent with past practice; or

 

(g)       any entering
into a Contract or committing to do or engage in any of the foregoing.

 

5.12       Foreign
Corrupt Practices Act.

 

Harris FRC has
not (nor has any officer, director, employee, consultant or other Person associated with or acting on behalf of Harris FRC), directly
or indirectly, (a) made, offered to make or promised to make any payment or transfer of anything of value, directly or indirectly, to (i)
anyone working in an official capacity for any governmental authority, including any employee of any government-owned or controlled entity
or public international organization or (ii) any political party, official of a political party or candidate for political office, in
order to obtain or retain business, or secure any improper business advantage, except for the payment of fees required by Law
to be paid to Governmental Entities, (b) made any unreported political contribution, (c) made or received any payment that was
not legal to make or receive, (d) engaged in any transaction or made or received any payment that was not properly recorded on its books, (e)
created or used any “off-book” bank or cash account or “slush fund,” or (f) engaged in any conduct constituting
a violation of the United States Foreign Corrupt Practices Act of 1977, as amended, the United Kingdom Bribery Act 2010, as amended,
or any Law of similar effect in any jurisdiction, if any, to which that Person is subject.

  

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -13-

     

    

 

5.13       OFAC
and September 24, 2001 Executive Order.

 

The
designated Nationals and Blocked Persons List maintained by the Office of Foreign Assets Control, Department of the Treasury (“OFAC”)
or any similar list maintained by OFAC is not applicable to Harris FRC or any shareholder or other equity owner of Harris FRC. The September
24, 2001 Executive Order Blocking Property and Prohibiting Transactions with Persons who Commit, Threaten to Commit, or Support Terrorism
is not applicable to Harris FRC or any member or other equity owner of Harris FRC.

 

5.14       Employees.

 

(a)      
Schedule 5.14(a) sets out a true, correct and complete list of the names and titles/positions of the employees of Harris FRC or
any Affiliates of Harris FRC (the employees set out on Schedule 5.14(a), collectively, the “Business Employees”).

 

(b)       
Schedule 5.14(b) sets out a true, correct and complete list of each Employee Benefit Plan that covers any Business Employee.

 

(c)       
For purposes of this Section 5.14(c), the term “Harris FRC” shall include any ERISA Affiliate.

 

(i)       
Harris FRC does not sponsor, maintain or contribute to, and has never sponsored, maintained, or contributed to, or had any liability
with respect to, any employee benefit plan which (i) is subject to the minimum funding standards of Section 302 of ERISA or Section
412 of the Code or Title IV of ERISA; or (ii) is a “multiemployer plan” as defined in Section 3(37) of ERISA. Harris FRC
has not: (A) withdrawn from any pension plan under circumstances resulting (or expected to result) in liability or (B) engaged in any
transaction which would give rise to a liability under Section 4069 or Section 4212(c) of ERISA.

 

(ii)       
Other than as required under Section 4980B of the Code or other applicable Law, no Employee Benefit Plan listed on Schedule 5.14(b)
provides benefits or coverage of the nature of health, life or disability insurance following retirement or other termination of
employment (other than death benefits when termination occurs upon death).

 

(iii)       
As of the Closing Date, Purchaser does not, and shall not, either directly or indirectly, have any obligation or Liability, as a matter
of Law or otherwise, with respect to any Employee Benefit Plan that was, or is, sponsored or maintained by Harris FRC or to which Harris
FRC contributes or which Harris FRC had, or may have, any Liability, contingent or otherwise, either directly or indirectly through an
ERISA Affiliate.

 

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -14-

     

    

 

5.15       No
Other Representations and Warranties.

 

Except for the
representations and warranties contained in this Article V (including the related portions of the Schedules), neither Harris FRC nor
any other Person has made or makes any other express or implied representation or warranty, either written or oral, on behalf of
Harris FRC, including any representation or warranty as to the accuracy or completeness of any information, documents or material regarding
the Product and the Purchased Assets furnished or made available to Purchaser and its Representatives in any form (including the Confidential
Project Gray Bee Acquisition Opportunity – Small Molecule Drug Royalty System prepared by Imperial Capital, any information, documents,
or material made available to Purchaser in any virtual data room maintained by or on behalf of Harris FRC related to the Contemplated
Transactions or any management presentations made in expectation of the Contemplated Transactions), or as to the future revenue, profitability,
or success of the Product or the Purchased Assets, or any representation or warranty arising from statute or otherwise in Law. All other
representations or warranties, including any warranty with respect to merchantability or fitness for any particular purpose, are hereby
expressly disclaimed and shall not be deemed to be or to include representations or warranties of Harris FRC and have not been relied
upon by Purchaser or any of its Affiliates in executing, delivering and performing this Agreement and the Contemplated Transactions.
Except as is otherwise provided in this Agreement, all of the assets and liabilities to be sold, conveyed, assigned, transferred or assumed,
as applicable, in accordance with this Agreement, shall be sold, conveyed, assigned, transferred or assumed on an “as is, where
is” basis.

 

5.16       Solvency.

 

After giving effect
to the Contemplated Transactions, Harris FRC will (a) be able to pay its debts as they become due, (b) own property having a fair saleable
value greater than the amounts required to pay its debts (including a reasonable estimate of the amount of all contingent liabilities)
and (c) have adequate capital to carry on its business. No transfer of property is being made and no obligation is being incurred in
connection with the transactions contemplated by this Agreement with the intent of Harris FRC or its Affiliates to hinder, delay or defraud
either present or future creditors of Harris FRC.

 

ARTICLE VI

 

REPRESENTATIONS AND WARRANTIES
OF PURCHASER

 

Purchaser hereby
represents and warrants to Harris FRC as of the date hereof and as of the Closing Date as follows:

 

6.1       Organization;
Good Standing.

 

Purchaser is a
limited partnership duly organized, validly existing and in good standing under the Laws of the State of Delaware.

 

6.2       Authority;
Noncontravention; Consents.

 

(a)       
Purchaser has all requisite partnership power and authority to enter into this Agreement and each Related Document to which it is a party,
to perform its obligations hereunder and thereunder and to complete the Contemplated Transactions. The execution and delivery by Purchaser
of this Agreement and each Related Document to which Purchaser is a party, and the performance by Purchaser of its obligations hereunder
and thereunder, have been duly and validly authorized by all necessary partnership action on the part of Purchaser. This Agreement
and each Related Document to which Purchaser is a party have been duly and validly executed and delivered by Purchaser and are the valid
and binding obligations of Purchaser, enforceable against Purchaser in accordance with their terms.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -15-

     

    

  

(b)      
Neither the execution and delivery by Purchaser of this Agreement and each Related Document to which Purchaser is a party, nor the performance
by Purchaser of any of its obligations hereunder and thereunder, nor the completion of the Contemplated Transactions, (i) conflicts
with, or results in a violation of, or causes a breach or default (with or without notice or lapse of time, or both) under, or gives
rise to a right of termination, amendment, cancellation or acceleration of any obligation contained in or the loss of any material benefit
under, any term, condition or provision of (y) Purchaser’s Fundamental Documents or (z) any Contract to which Purchaser is a party
or by which its assets are bound, or (ii) violates any Laws applicable to Purchaser or any of its assets.

 

(c)       
Except as set out on Schedule 6.2, no (i) consent, (ii) approval, (iii) Order or authorization of, (iv) registration, declaration
or filing with, or (v) notification to any Governmental Entity or any other third Person is required in connection with the execution
and delivery by Purchaser of this Agreement or the Related Documents to which Purchaser is a party or the completion of the Contemplated
Transactions.

 

(d)       
Purchaser is its own ultimate parent entity (as defined under the HSR Act and regulations), does not have any regularly prepared balance
sheet and does not satisfy any of the “size of person” jurisdictional thresholds applicable to Purchaser under the HSR Act.

 

6.3       Brokers.

 

Neither Purchaser
nor any of its officers, directors, equity owners or employees nor any other Person acting on its or their behalf has employed or engaged
any broker or finder, or incurred any Liability for any brokerage fees, commissions, finders’ fees or similar fees, in connection
with the Contemplated Transactions. To the extent that Purchaser has incurred any Liability for any brokerage fees, commissions, finder’s
fees or similar fees in connection with the Contemplated

Transactions, Purchaser will be solely responsible for the
payment of those commissions or fees.

 

6.4       Litigation,
Etc.

 

There are no (i)
Proceedings pending or, to the Knowledge of Purchaser, threatened against Purchaser, whether at law or in equity, or before or by any
Governmental Entity or arbitrator or (ii) Orders of any Governmental Entity or arbitrator naming Purchaser, in each case challenging,
enjoining or seeking to prevent the performance of this Agreement or the completion of the Contemplated Transactions.

 

6.5       Solvency.

 

Immediately after
giving effect to the Contemplated Transactions, Purchaser shall be solvent and shall: (a) be able to pay its debts as they become due;
(b) own property that has a fair saleable value greater than the amounts required to pay its debts (including a reasonable estimate of
the amount of all contingent liabilities); and (c) have adequate capital to carry on its business. No transfer of property is being made
and no obligation is being incurred in connection with the Contemplated Transactions with the intent of Purchaser or its Affiliates to
hinder, delay or defraud either present or future creditors of Purchaser. In connection with the Contemplated Transactions, Purchaser
has not incurred, nor plans to incur, debts beyond its ability to pay as they become absolute and matured.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

  

    -16-

     

    

 

6.6       Sufficiency
of Funds.

 

Purchaser has or
will have at the Closing sufficient cash on hand or other sources of immediately available funds to enable it to make payment of the
Cash Payment and complete the Contemplated Transactions.

 

6.7       Independent
Investigation.

 

Purchaser has conducted
its own independent investigation, review and analysis of Harris FRC and the Purchased Assets, and acknowledges that it has been provided
adequate access to the personnel, properties, assets, books and records, and other documents and data of Harris FRC for that purpose.
In making its decision to enter into this Agreement and to complete the Contemplated Transactions, Purchaser has relied solely upon its
own investigation and the express representations and warranties of Harris FRC set out in Article V of this Agreement (including
related portions of the Schedules to this Agreement).

 

ARTICLE VII

 

CONDUCT AND TRANSACTIONS
BEFORE AND AT CLOSING

 

7.1       Conduct
of Business Prior to Closing.

 

From the date of
this Agreement until the earlier of the termination of this Agreement and the Closing Date (the “Pre-Closing Period”),
except as otherwise provided in this Agreement or consented to in writing by Purchaser (which consent shall not be unreasonably withheld
or delayed), Harris FRC shall (a) conduct the Business and maintain the Purchased Assets in the ordinary course of business, (b) maintain
its corporate existence and (c) pay or perform its Liabilities when due. Without limiting the generality of the foregoing, except with
the prior written consent of Purchaser, during the Pre-Closing Period, Harris FRC shall not: (i) adopt or amend any of its organizational
or governance documents in any way that would reasonably be expected to delay the completion of the Contemplated Transactions; (ii) enter
into any contract, agreement or arrangement materially impacting any of the Purchased Assets; (iii) amend, modify, cancel or waive any
material rights under any Assigned Contract; (iv) take any action or enter into any agreement or arrangement that could alter the amount,
duration or determination of any royalties or other payments due to or owed by Harris FRC in any manner that would reasonably be expected
to affect the rights or obligations of Purchaser after the Closing under any Assigned Contract; (v) authorize for issuance, issue,
sell or deliver any capital stock of, or other equity or voting interest in, Harris FRC, or any securities convertible into, exchangeable
for, or evidencing the right to subscribe for or acquire any shares of capital stock of, or other equity or voting interest in, Harris
FRC; or (vi) agree, whether in writing or otherwise, to do any of the foregoing.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -17-

     

    

 

7.2       Access
to Information.

 

During the Pre-Closing
Period, Harris FRC shall afford, and shall cause its Representatives to afford, as applicable, to Purchaser, its Affiliates and their
respective Representatives, as may be reasonably requested, access, during normal business hours or at such other times as may be agreed
upon by Harris FRC and Purchaser and subject to reasonable precautions related to the COVID-19 epidemic, to (a) the personnel of Harris
FRC and (b) to the extent they relate to the Purchased Assets, all of the properties, books and records, Tax Returns, work papers and
other documents and information of Harris FRC, including any correspondence, communication with any Governmental Entity or regulatory
or quasi regulatory authority, and to the audit work papers and other records of the independent public accountants of Harris FRC. Harris
FRC shall, at Purchaser’s request, provide to Purchaser copies of all such work papers, documents and other written information.

 

7.3       Efforts
to Complete.

 

Subject to the
terms and conditions of this Agreement, each Party shall use commercially reasonable efforts to take or cause to be taken all actions
and do or cause to be done all things required under all applicable Laws or this Agreement in order to timely complete the Contemplated
Transactions. Without limiting the preceding sentence, each Party shall, effective as of and subject to the occurrence of the Closing,
execute and deliver each agreement, certificate or other document to be executed or delivered by that Party under this Agreement at or
before the Closing and cooperate in the transferring of the Transferred Intellectual Property.

 

7.4       Supplement
to Schedules.

 

From time to time
prior to the Closing, Harris FRC shall have the right (but not the obligation) to supplement or amend the Schedules to this Agreement
with respect to any matter arising after the date of this Agreement (each a “Schedule Supplement”). Any disclosure
in any such Schedule Supplement shall not be deemed to have cured any inaccuracy in or breach of any representation or warranty contained
in this Agreement, including for purposes of the indemnification or termination rights contained in this Agreement or of determining
whether or not the conditions set out in Section 8.2 have been satisfied; provided, however, that if Purchaser has the right to,
but does not elect to, terminate this Agreement within ten Business Days of its receipt of that Schedule Supplement, then Purchaser shall
be deemed to have irrevocably waived any right to terminate this Agreement with respect to that matter and, further, shall have irrevocably
waived its right to indemnification under Section 9.1 with respect to that matter; provided, further, however, that notwithstanding
the foregoing, no Schedule Supplement shall affect or limit Purchaser’s rights to indemnification under Sections 9.1(a)(ii),
9.1(a)(iii) or 9.1(a)(iv).

 

7.5       Exclusivity.

 

During the Pre-Closing
Period, Harris FRC shall not, and shall direct and cause its Representatives not to, directly or indirectly: (i) solicit, encourage,
initiate or otherwise facilitate any inquiries or the making of any proposal or offer with respect to or related to Another Transaction,
(ii) conduct any discussions, enter into any negotiations or provide any information to any Person with respect to or related to
Another Transaction, or (iii) enter into Another Transaction or any agreement, arrangement or understanding related to Another Transaction
with any Person. Upon completion of the Closing, Purchaser’s rights under this Section 7.5 shall terminate and Purchaser
shall be deemed to have waived any potential claims for breaches of this Section 7.5.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -18-

     

    

 

7.6       Government
Approvals and Consents.

 

Each Party shall,
as promptly as possible, use its best efforts to obtain, or cause to be obtained, all consents, authorizations, orders and approvals
from all Governmental Entities that may be or become necessary for its execution and delivery of this Agreement and the performance of
its obligations under to this Agreement and the Related Documents. Each Party shall cooperate fully with the other Party and its Affiliates
in promptly seeking to obtain all such consents, authorizations, orders and approvals. The Parties shall not willfully take any action
that will have the effect of delaying, impairing or impeding the receipt of any required consents, authorizations, orders and approvals.

 

7.7       Shareholder
Meeting.

 

As soon as practicable
following the date of this Agreement (but in any event no later than 30 days following the date hereof), Harris FRC shall hold a shareholders’
meeting, duly called and convened in accordance with applicable Law and the Fundamental Documents of Harris FRC, for the purpose of approving
this Agreement and the Contemplated Transactions including complying with all notice requirements to shareholders as required under applicable
Law. Included in the notice to shareholders, Harris FRC shall submit to the shareholders all materials and information as is required
pursuant to applicable Law. Promptly following the shareholders’ meeting, Harris FRC shall deliver a copy of the minutes of the
shareholders’ meeting evidencing the Requisite

Shareholder Approval certified by the Secretary of Harris
FRC.

 

ARTICLE VIII

 

CLOSING CONDITIONS

 

8.1       Conditions
to the Obligations of Both Parties.

 

The obligations
of each Party to complete the Contemplated Transactions are subject to the satisfaction, at or before the Closing, of the following condition,
unless waived (to the extent those conditions can be waived) by the other Party:

 

(a)       
No Governmental Entity shall have enacted, issued, promulgated, enforced or entered any Order which is in effect and has the effect of
making the Contemplated Transactions illegal or otherwise materially restraining or prohibiting completion of those transactions.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -19-

     

    

 

8.2       Conditions
to the Obligations of Purchaser.

 

The obligations
of Purchaser to complete the Contemplated Transactions are subject to the satisfaction, at or before the Closing, of the following conditions,
unless waived (to the extent those conditions can be waived) by Purchaser:

 

(a)       
Accuracy of Representations and Warranties. All representations and warranties made by Harris FRC in this Agreement and the Related
Documents shall be true and correct in all material respects, except to the extent that those representations and warranties are
qualified by any of the terms “material,” and “in all material respects,” “Material Adverse Change”
or similar terms, in which case those representations and warranties shall be true and correct in all respects as so written, on and
as of the Closing Date with the same effect as if those representations and warranties had been made at and as of the Closing Date, except
for those representations and warranties that address matters only as of a particular date (which shall be true and correct in all material
respects as of that date).

 

(b)       
Performance of Covenants. Harris FRC shall have in all material respects performed and complied with all agreements, obligations
and covenants required to be performed or complied with by it under this Agreement and the Related Documents on, prior to or as of the
Closing Date.

 

(c)       
Requisite Shareholder Approval. The Requisite Shareholder Approval shall have been obtained, and the Requisite Shareholder Approval
shall not have been revoked, withdrawn or amended in any way prior to the Closing.

 

(d)       
Related Documents. At the Closing, Harris FRC shall execute and deliver (or cause such other Person to execute and deliver, as
applicable) to Purchaser each of the documents listed below (collectively, the “Related Documents”):

 

(i)       a
Bill of Sale, Assignment and Assumption Agreement substantially in the form contained in Exhibit A;

 

(ii)       separate
assignments of Trademarks, copyrights, Know-How and regulatory approvals, substantially in the forms contained in Exhibit B;

 

(iii)       one
or more Consulting Agreements substantially in the form contained in Exhibit C;

 

(iv)       
a non-foreign affidavit dated as of the Closing Date, sworn under penalty of perjury and in the form and substance required under the
Treasury Regulations issued under Code §1445 stating that Harris FRC is not a “foreign person” as defined in

Code §1445, in the form contained in Exhibit D,
and an IRS Form W-9; and

 

(v)       the Escrow
Agreement.

 

(e)       Related Certificates.
At the Closing, Harris FRC shall deliver the certificates set out below to Purchaser, executed by the Person set out below:

  

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -20-

     

    

 

(i)             a
certificate of an officer of Harris FRC dated as of the Closing Date, certifying: (A) as to the incumbency and genuineness of the signatures
of the officer of Harris FRC executing this Agreement or any of the Related Documents on behalf of Harris FRC; (B) the genuineness of
the resolutions (attached thereto) of Harris FRC’s Board of Directors and the majority of Harris FRC’s shareholders, duly
adopted and in effect, authorizing the execution, delivery and performance of this Agreement and the Related Documents to which Harris
FRC is a party and the completion of the Contemplated Transactions; and (C) the genuineness and full force and effect of the Fundamental
Documents of Harris FRC (attached thereto);

 

(ii)            a
certificate of Harris FRC dated as of the Closing Date certifying that the conditions set out in Sections 8.2(a), 8.2(b),
8.2(c) and 8.2(f) have been satisfied.

 

(iii)          a
certificate, dated within 15 Business Days of the Closing Date, of the Treasurer of the State of New Jersey certifying as to the good
standing of Harris FRC.

 

(f)        
No Material Adverse Change. There shall not have occurred a Material Adverse Change since the date of this Agreement.

 

8.3       Conditions
to the Obligations of Harris FRC.

 

The obligations
of Harris FRC to complete the Contemplated Transactions are subject to the satisfaction, at or before the Closing, of the following conditions,
unless waived (to the extent those conditions can be waived) by Harris FRC.

 

(a)         Accuracy
of Representations and Warranties. The representations and warranties made by Purchaser in this Agreement and the Related Documents
shall be true and correct in all material respects, except to the extent that those representations and warranties are qualified
by any of the terms “material,” and “in all material respects,” “Material Adverse Change” or similar
terms, in which case those representations and warranties shall be true and correct in all respects as so written, on and as of the Closing
Date with the same effect as if those representations and warranties had been made at and as of the Closing Date, except for those representations
and warranties that address matters only as of a particular date (which shall be true and correct in all material respects as of that
date).

 

(b)        
Performance of Covenants. Purchaser shall have in all material respects performed and complied with all agreements, obligations
and covenants required to be performed or complied with by it under this Agreement and the Related Documents on, prior to or as of the
Closing Date.

 

(c)        
Related Documents. At the Closing, Purchaser shall execute and deliver to Harris FRC each Related Document to which Purchaser
is a party.

 

(d)        
Related Certificates. At the Closing, Purchaser shall deliver the certificates set out below to Harris FRC, executed by the Person
set out below:

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -21-

     

    

 

(i) a certificate
of an officer, general partner or similar governing person of Purchaser dated as of the Closing Date, certifying (A) as to the incumbency
and genuineness of the signatures of each officer, general partner or similar governing person of Purchaser executing this Agreement
or any of the Related Documents on behalf of Purchaser; and (B) the genuineness of the resolutions (attached thereto) of Purchaser’s Board
of Directors or similar governing body authorizing the execution, delivery and performance of this Agreement and the Related Documents
to which Purchaser is a party and the completion of the transactions contemplated hereby and thereby; and

 

(ii) a certificate
of the Delaware Secretary of State certifying as to the good standing of Purchaser.

 

(iii) a certificate
of Purchaser dated as of the Closing Date certifying that the conditions set out in Sections 8.3(a) and 8.3(b) have been
satisfied.

 

ARTICLE IX

 

INDEMNIFICATION

 

9.1       Indemnification
Generally; Etc.

 

(a)           Subject
to the further terms of this Article IX, the Harris FRC Indemnifying Persons shall indemnify and reimburse the Purchaser Indemnified
Persons for, and hold each of them harmless from and against, any and all Purchaser Losses arising from, relating to or in connection
with any of the following:

 

(i)        the
inaccuracy or breach of any representation or warranty of Harris FRC contained in this Agreement or in any Related Document to which
Harris FRC is a party;

 

(ii)         the
breach of any agreement or covenant of Harris FRC contained in this Agreement or in any Related Document to which Harris FRC is a party;

 

(iii)       the Excluded
Liabilities; and

 

		(iv)	the Shareholder Claims.

 

(b)          
Subject to the further terms of this Article IX, the Purchaser Indemnifying Persons shall indemnify and reimburse
the Harris FRC Indemnified Persons for, and hold each of them harmless from and against, any and all Harris FRC Losses arising
from, relating to or in connection with any of the following:

  

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -22-

     

    

 

 

 

	 	(i)	the inaccuracy or breach of any representation or warranty of Purchaser contained
    in this Agreement or in any Related Document to which Purchaser is a party;

 

	 	(ii)	the breach of any agreement or covenant of Purchaser contained in this Agreement
    or in any Related Document to which Purchaser is a party; and

 

		(iii)	the
                                            Assumed Liabilities.

 

		9.2	Assertion of Claims.

 

No claim shall be brought under Section
9.1 unless the Indemnified Persons, or any of them, at any time before the applicable Survival Date, give the Indemnifying Persons
(i) written notice of the existence of that claim, specifying the nature and basis of that claim and the amount of Losses relating thereto,
to the extent known, or (ii) written notice under Section 9.3 of any third Person claim, the existence of which might give rise
to such a claim. No delay in or failure to give such notice or the giving of an incomplete or inaccurate notice shall adversely affect
any of the other rights or remedies which the Indemnified Person has under this Agreement, or alter or relieve any Indemnifying Person
of its obligation to indemnify the Indemnified Person, except and only to the extent that such delay or failure results in actual and
material prejudice to the Indemnifying Person; provided; however, that the foregoing shall in no way serve to extend or
otherwise lengthen the survival of representations and warranties in accordance with Section 9.4 or the applicable time limits
on making an indemnification claim under this Article IX. Upon the giving of written notice of an indemnification claim in accordance
with the preceding provisions of this Section 9.2 or Section 9.3, the Indemnified Persons’ rights under Section
9.1 with respect to that indemnification claim shall survive the Survival Date until that indemnification claim is finally determined,
and the Indemnified Persons, or any of them, shall have the right to commence legal proceedings subsequent to the Survival Date for the
enforcement of their rights under Section 9.1.

 

	 	9.3	Notice and Defense of Third Person Claims.

 

The obligations
and liabilities of an Indemnifying Person with respect to Losses resulting from the assertion of liability by third Persons (each, a
 “Third Person Claim”) shall be subject to the following terms and conditions:

 

(a)    
An Indemnified Person shall promptly give written notice to the Indemnifying Persons of any Third Person Claim that might give rise to
any Losses by the Indemnified Persons, stating the nature and basis of that Third Person Claim, and the amount of Losses related thereto
to the extent known; provided, however, that no delay on the part of the Indemnified Persons in notifying any Indemnifying
Persons shall relieve the Indemnifying Persons from any liability or obligation hereunder unless (and then solely to the extent that)
the Indemnifying Person is prejudiced by the delay. That notice shall be accompanied by copies of all relevant documentation with respect
to the Third Person Claim, including any summons, complaint or other pleading which may have been served, any written demand or any other
related document or instrument.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -23-

     

    

 

(b)    
If the Indemnifying Persons acknowledge in a writing (in form and substance reasonably satisfactory to the Indemnified Persons) delivered
to the Indemnified Persons that the Indemnifying Persons shall be obligated under the terms of their indemnification obligations hereunder
in connection with a Third Person Claim that is not a Shareholder/Purchaser Claim, then the Indemnifying Persons shall have the right
to assume the defense of that Third Person Claim at their own expense and by their own counsel, which counsel shall be reasonably satisfactory
to the Indemnified Persons; provided, that, the Indemnifying Person may only assume the defense of a Third Person Claim if (i)
the defense of that Third Person Claim by the Indemnifying Person does not, and would not reasonably be likely to, result in a Material
Adverse Change on the business of the Indemnified Person (including the Business) and (ii) the Indemnifying Person has sufficient financial
resources to satisfy the amount of any adverse monetary judgment that is reasonably likely to result. “Shareholder/Purchaser
Claim” means a Shareholder Claim asserted against any Purchaser Indemnified Person. This Section 9.3(b) and Sections
9.3(c)–(d) shall not apply to Shareholder/Purchaser Claims, which shall instead be covered by Sections 9.3(a) and (e)–(g).

 

(c)    
If the Indemnifying Persons assume the defense of a Third Person Claim, the Indemnifying Persons shall not be responsible for any legal
or other defense costs subsequently incurred by the Indemnified Persons in connection with the defense thereof, but the Indemnified Persons
shall nevertheless be entitled to participate in that defense with their own counsel and at their own expense. If the Indemnifying Persons
do not exercise their right to assume the defense of a Third Person Claim by giving the written acknowledgement referred to in Section
9.3(b), the Indemnified Persons may defend the Third Person Claim and seek indemnity from the Indemnifying Persons for Litigation
Expenses incurred in connection with that defense.

 

(d)    
If the Indemnifying Persons exercise their right to assume the defense of a Third Person Claim, they shall not make any settlement of
any claims without the prior written consent of the Indemnified Persons, which consent shall not be unreasonably withheld; provided,
however, that if the Indemnifying Persons (i) propose the settlement of any Third Person Claim on terms that require the payment
of money only and include a full and unconditional release of the Indemnified Persons in connection with that Third Person Claim and
(ii) demonstrate to the reasonable satisfaction of the Indemnified Persons that the Indemnifying Persons are able to pay the required
amount of money, and the Indemnified Persons do not consent thereto within 20 days after the receipt of written notice thereof, any Losses
incurred by the Indemnified Persons in excess of that proposed settlement shall be at the sole expense of the Indemnified Persons.

 

(e)    
The Purchaser Indemnified Persons shall diligently and reasonably defend each Shareholder/Purchaser Claim with reasonable, qualified
counsel selected by the Purchaser Indemnified Persons, and the reasonable fees and expenses of that counsel and any other Litigation
Expenses incurred by the Purchaser Indemnified Persons (including pursuant to Section 9.3(g)) in connection with a Shareholder/Purchaser
Claim, whether during the defense of a Shareholder/Purchaser Claim or thereafter, shall be indemnifiable Losses under Section 9.1(a)(iv).

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -24-

     

    

 

(f)    
The Purchaser Indemnified Persons shall not settle any Shareholder/Purchaser Claim without the prior written consent of Harris FRC, which
shall not be unreasonably withheld (it being understood that withholding consent on any settlement that does not (i) involve the release
of money from the Escrow Account or (ii) require any obligations on Harris FRC shall be deemed unreasonable), except that the
Purchaser Indemnified Persons may enter into a Qualifying Unilateral Settlement in their sole discretion, without the consent of Harris
FRC, in which case the Purchaser Indemnifying Persons shall not be entitled to, and shall be deemed to have irrevocably waived and released,
any and all right to indemnification under this Article IX and any and all other remedies that the Purchaser Indemnifying Persons,
or any of them, may have against the Harris FRC Indemnifying Persons, or any of them, solely in connection with (i) that Qualifying Unilateral
Settlement, including the amount paid in that Qualifying Unilateral Settlement, or (ii) any subsequent Losses solely in connection with
that Shareholder/Purchaser Claim. A “Qualifying Unilateral Settlement” means a settlement of a Shareholder/Purchaser
Claim that finally resolves that Shareholder/Purchaser Claim by a payment of money only, at the sole expense of the Purchaser
Indemnified Persons, in exchange for a full and unconditional release of the Purchaser Indemnified Persons in that Shareholder/Purchaser
Claim. For the avoidance of doubt, entry into a Qualifying Unilateral Settlement shall not otherwise release the Harris FRC Indemnifying
Persons, or any of them, from their obligation to indemnify the Purchaser Indemnified Parties under this Article IX.

 

(g)    
The Purchaser Indemnified Persons and Harris FRC shall consult and cooperate reasonably with one another in connection with the defense
of any Shareholder/Purchaser Claim, including considering in good faith the views of one another concerning strategy in that defense
and material submissions (including memoranda, briefs and arguments), negotiations (including settlement negotiations) and other material
actions in connection with that defense, and reasonably exchanging information in connection with that defense, subject to appropriate
confidentiality protections. However, (i) nothing in this Section 9.3(g) shall be deemed to be a waiver of any legal privilege
of any Person or require any Person to take any action that would result in any such waiver, and (ii) the Purchaser Indemnified Persons
shall remain in ultimate control of the defense of any Shareholder/Purchaser Claim, subject to the limitations set out in Sections
9.3(e) and (f).

 

	 	9.4	Survival of Representations and Warranties and Covenants.

 

(a)    
The representations and warranties (other than Fundamental Representations) of Harris FRC contained in this Agreement or in any certificate
delivered in connection with this Agreement shall survive the Closing until 12 months after the Closing Date, at which time they shall
terminate, provided that the Fundamental Representations shall survive the Closing until 60 days after the expiration of the applicable
statute of limitations, at which time they shall terminate. The covenants and other agreements of Harris FRC in this Agreement shall
survive the Closing Date until fully performed or satisfied or until they terminate in accordance with their own terms.

 

(b)    
The representations and warranties of Purchaser contained in this Agreement or in any certificate delivered in connection with this Agreement
shall survive the Closing Date and shall terminate 12 months after the Closing Date, provided that the representations and warranties
of Purchaser contained in Sections 6.1, 6.2 and 6.3 shall survive the Closing until 60 days after the expiration
of the applicable statute of limitations. The covenants and other agreements of Purchaser contained in this Agreement shall survive the
Closing Date until fully performed or satisfied or until they terminate in accordance with their own terms.

 

(c)    
For convenience of reference, the date upon which any representation, warranty, covenant or agreement contained herein shall terminate,
if any, is referred to herein as the “Survival Date.”

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -25-

     

    

 

	 	9.5	Limitations on Indemnification.

 

(a)       Indemnity
Limitations for Harris FRC Indemnifying Persons. Except in the

case of Fraud:

 

(i)
     the Purchaser Indemnified Persons shall not have the right to be indemnified under Section 9.1(a)(i),
except for any inaccuracy or breach of Fundamental Representations, unless and until the Purchaser Indemnified Persons (or any of them)
incur on a cumulative basis aggregate Purchaser Losses in an amount exceeding [*]  (the “Threshold”),
in which case the Purchaser Indemnified Persons’ right to be" indemnified shall apply from the first dollar of those Purchaser
Losses; and

 

(ii)
     the sum of all Purchaser Losses for which indemnification is payable by the Harris FRC Indemnifying Persons under
Section 9.1(a) shall not exceed [*]  (the “Cap”), except for Shareholder Claims, Excluded Liabilities
and claims for inaccuracy or breach of Fundamental Representations, for which the sum of all Purchaser Losses for which indemnification
is payable by the Harris FRC Indemnifying Persons under Section 9.1(a) shall not exceed the amount of the Cash Payment.

 

(b)       
Indemnity Limitations for the Purchaser Indemnifying Persons. Except in the case of Fraud:

 

(i)     
the Harris FRC Indemnified Persons shall not have the right to be indemnified under Section 9.1(b)(i) unless and until the Harris
FRC Indemnified Persons (or any of them) incur on a cumulative basis aggregate Harris FRC Losses in an amount exceeding the Threshold,
in which case the Harris FRC Indemnified Persons’ right to be indemnified shall apply from the first dollar of those Harris FRC
Losses; and

 

(ii)     
the sum of all Harris FRC Losses for which indemnification is payable by the Purchaser Indemnifying Persons under Section 9.1(b)
shall not exceed the Cap.

 

(c)      
DAMAGES LIMITATION. IN NO EVENT SHALL EITHER PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTY TO THIS AGREEMENT, UNDER THIS
AGREEMENT OR OTHERWISE IN CONNECTION WITH THE SUBJECT MATTER OF THIS AGREEMENT, FOR PUNITIVE, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR INDIRECT
DAMAGES, INCLUDING LOSS OF FUTURE REVENUE OR INCOME, LOSS OF BUSINESS REPUTATION OR OPPORTUNITY, OR DIMINUTION OF VALUE OR ANY DAMAGES
BASED ON ANY TYPE OF MULTIPLE, EXCEPT, IN EACH CASE, (i) IN THE EVENT OF FRAUD, (ii) TO THE EXTENT THAT AN INDEMNIFIED PERSON
IS REQUIRED TO PAY THOSE DAMAGES OR OTHER ITEMS TO A THIRD PERSON IN CONNECTION WITH A MATTER FOR WHICH THAT INDEMNIFIED PERSON IS ENTITLED
TO INDEMNIFICATION UNDER THIS ARTICLE IX; OR (III) THAT THE FOREGOING LIMITATIONS SHALL NOT LIMIT THE PURCHASER’S RIGHT
TO RECOVER FOR THE LOSS OF FUTURE ROYALTY PAYMENTS DUE UNDER ASSIGNED CONTRACTS THAT ARE REASONABLY FORSEEABLE AND DETERMINABLE.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -26-

     

    

 

(d)    
Duty to Mitigate. Each Indemnified Person shall take, and cause its Affiliates to take, all reasonable steps to mitigate any Loss
upon becoming aware of any event or circumstance that would be reasonably expected to, or does, give rise thereto, including incurring
costs only to the minimum extent reasonably necessary to remedy the breach that gives rise to that Loss.

 

(e)    
Exclusive Remedy. Except in the case of Fraud and to remedies to which a Party is entitled under Section 12.8, the rights
and remedies provided for in this Article IX shall be the sole and exclusive remedies of the Indemnified Persons with respect
to any matter arising under or related to this Agreement or the Contemplated Transactions.

 

9.6      [*]

 

[*]

 

ARTICLE X

 

POST-CLOSING COVENANTS

 

	 	10.1	Transfer of Purchased Assets.

 

Harris FRC shall
cooperate with Purchaser to facilitate the efficient and expeditious transfer to Purchaser of the Purchased Assets.

 

10.2       Publicity.

 

Purchaser and its
Affiliates may in their discretion issue press releases and otherwise make public announcements related to this Agreement and the Contemplated
Transaction. Harris FRC shall not, and shall cause its Affiliates not to, issue any press release or make any other public announcement,
written or oral, related to this Agreement or the Contemplated Transactions without Purchaser’s prior written consent.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -27-

     

    

 

10.3       Confidentiality.

 

The Confidentiality
Agreement dated as of January 3, 2020 (the “Confidentiality Agreement”), between Purchaser and Harris FRC, shall remain
in full force and effect in accordance with its terms. All information disclosed or made available by a Party to the other Party before
or after the Closing Date shall be subject to the terms of the Confidentiality Agreement, provided, however, that from
and after the Closing, all confidential information (which is defined as “Confidential Information” under the
Confidentiality Agreement) included in the Purchased Assets shall be treated as Confidential Information of Purchaser.

 

10.4       Consulting
Agreement.

 

From and after
the Closing, Harris FRC shall, or, if Harris FRC is not a party to the Consulting Agreement(s), shall cause the parties to the Consulting
Agreements (other than Purchaser or its Affiliates) to, comply with the terms and conditions of the Consulting Agreement(s), including
by providing the Services (as defined therein) in accordance with the terms thereof during the Consulting Period (as defined therein);
provided, that, Harris FRC shall have no Liability to Purchaser or its Affiliates for a Person’s failure to so comply in the event
that such failure is a result of such Person’s death or disability.

 

ARTICLE XI

 

TERMINATION

 

11.1       Termination.

 

This Agreement may be terminated at any time prior to the
Closing:

 

		(a)	by the mutual consent of Harris FRC and
                                            Purchaser;

 

(b)          by
Purchaser, if a breach of any representation or warranty or failure to perform any covenant or agreement, in each case on the part of
Harris FRC, set out in this Agreement, occurs that would cause the condition set out in Sections 8.2(a) or 8.2(b) not to
be satisfied, and that breach is incapable of being cured or is not cured by September 1, 2020 (the “Long-Stop Date”);

 

(c)           by
Harris FRC, if a breach of any representation or warranty or failure to perform any covenant or agreement, in each case on the part of
Purchaser, set out in this Agreement, occurs that would cause the condition set out in Sections 8.3(a) or 8.3(b) not to
be satisfied, and that breach is incapable of being cured or is not cured by the Long-Stop Date;

 

(d)           by
either Purchaser or Harris FRC if:

 

(i)       
any permanent injunction or other Order of a Governmental Entity preventing the Closing becomes final and non-appealable; or

 

(ii)       the Closing
is not completed on or before the Long-Stop Date;

 

provided,
however, that (A) Purchaser shall not be entitled to terminate this Agreement under Section 11.1(b) or 11.1(d)(ii) if its
breach of this Agreement has been the cause of or resulted in the failure of the condition to be satisfied, and (B) Harris FRC shall
not be entitled to terminate this Agreement under Section 11.1(c) or 11.1(d)(ii) if its breach of this Agreement has been
the cause of or resulted in the failure of the condition to be satisfied.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -28-

     

    

 

11.2       Termination
Procedures.

 

Any termination
under Section 11.1(a) shall be effected by a written instrument signed by Purchaser and Harris FRC, and any other termination
under Section 11.1 shall be effected by written notice from the Party so terminating to the other Party, which notice shall specify
the Section of this Agreement under which this Agreement is being terminated.

 

11.3       Effect
of Termination.

 

If this Agreement
is terminated as provided in Section 11.1, this Agreement shall immediately become null and void and of no further force or effect,
except (a) for this Section 11.3 and Article XII, each of which shall survive the termination of this Agreement; provided,
however, the Confidentiality Agreement shall survive, and (b) that nothing herein shall relieve any Party from liability for Fraud
or intentional breach of any provision of this Agreement.

 

ARTICLE XII

 

MISCELLANEOUS PROVISIONS

 

12.1       No
Third Party Beneficiaries.

 

This Agreement
and the Contemplated Transactions shall not confer any rights or remedies upon any Person other than the Parties and their respective
successors and permitted assigns.

 

12.2       Entire
Agreement.

 

This Agreement
and the Related Documents (including the schedules and the exhibits attached hereto) contain all of the agreements between the Parties
or their Affiliates with respect to the Contemplated Transactions and supersede all prior agreements or understandings, whether written
or oral, between the Parties or their Affiliates with respect thereto, including the Summary of Terms and Conditions, dated March 17,
2020, between Healthcare Royalty Management, LLC and Harris FRC.

 

12.3       Successors
and Assigns.

 

All the terms and
provisions of this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted
assigns. Neither Party may assign any of its rights or obligations hereunder without the prior written consent of the other Party, which
consent shall not be unreasonably withheld or delayed, except that prior to the Closing, Purchaser may assign this Agreement to
an Affiliate of Purchaser or to RCT (or an Affiliate of RCT), and from and after the Closing, Purchaser may assign any of its rights
and obligations under this Agreement or any Related Document without restriction.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -29-

     

    

 

12.4       Amendment;
Waiver.

 

This Agreement
shall not be altered or otherwise amended except pursuant to an instrument in writing signed by each Party. No obligation of Harris FRC
to Purchaser shall be waived except by means of a writing signed by Purchaser, and no obligation of Purchaser to Harris FRC shall be
waived except by means of a writing signed by Harris FRC. No waiver by either Party of any default, misrepresentation, or breach of warranty
or covenant hereunder, whether intentional or not, shall be deemed to extend to any prior or subsequent default, misrepresentation, or
breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.

 

12.5       Fees
and Expenses.

 

Subject to Article
IX and except as otherwise set out in this Agreement, each Party shall bear its own fees and expenses incurred in connection with
this Agreement and the Related Documents and the completion of the Contemplated Transactions, including the legal, accounting and due
diligence fees, costs and expenses incurred by that Party. The Escrow Agent’s fees shall be paid one-half by Harris FRC and one-half
by Purchaser. The Expense Reimbursement Amount shall be paid by Harris FRC to Purchaser (a) if the Closing occurs, as a reduction to
the Purchase Price in accordance with Section 3.1, or (b) if this Agreement is terminated (other than under Section 11.1(c)),
by wire transfer of immediately available United States dollars to an account designated by Purchaser within five Business Days after
that termination.

 

12.6       Notices.

 

All notices, amendments,
waivers, or other communications pursuant to this Agreement shall be in writing and shall be deemed to be sufficient if delivered personally,
sent by e-mail, sent by nationally-recognized overnight courier or mailed by registered or certified mail (return receipt requested),
postage prepaid, to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice):

 

		(a)	if to Purchaser, to:

 

c/o HealthCare Royalty Partners IV, LP

300 Atlantic Street, Suite 600

Stamford, CT 06901

Attention:     Clarke
B. Futch

Telephone:   (203) 487-8301

E-mail:
         clarke.futch@hcroyalty.com

 

with a copy to:

 

Morgan, Lewis & Bockius LLP

1701 Market Street

Philadelphia, PA 19103-2921

Attention:     Andrew R. Mariniello

Telephone:   (215) 963-4947

E-mail:          andrew.mariniello@morganlewis.com

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -30-

     

    

 

		(b)	if to Harris FRC to:

 

Harris FRC Corporation

1715 Route 35, Suite 304

Middletown, New Jersey 07748

Attention:     Paul
M. Petigrow, Vice President

Telephone:   (732) 739-2018

E-mail:           ppetigrow@harrisfrc.com

 

with a copy to:

 

Carter Ledyard & Milburn LLP

2 Wall Street

New York, New York 10005-2072

Attention:     Keith Nowak, Esq.

John M. Griem, Esq.

Bryan J. Hall, Esq.

  Telephone:    (212) 732-3200

  E-mail:          nowak@clm.com

greim@clm.com

hall@clm.com

 

All notices
and other communications shall be deemed to have been delivered and received (i) in the case of personal
delivery or delivery by e-mail, on the date of delivery if delivered during business hours on a Business Day or, if not delivered during
business hours on a Business Day, the first Business Day thereafter, (ii) in the case of delivery by nationally-recognized overnight
courier, on the Business Day delivered, and (iii) in the case of mailing, on the 5 th
Business Day following mailing.

 

12.7       Governing
Law; Jurisdiction and Venue; Waiver of Jury Trial.

 

(a)           All
questions concerning the construction, interpretation and validity of this Agreement and all claims or causes of action (whether in contract
or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement
shall be governed by and construed and enforced in accordance with the domestic Laws of the State of New York, without giving effect
to any choice or conflict of Law provision or rule, whether in the State of New York or any other jurisdiction, that would cause the
Laws of any jurisdiction other than the State of New York to apply. In furtherance of the foregoing, the internal Law of the State of
New York shall control the interpretation and construction of this Agreement, even if under the State of New York’s choice of Law
or conflict of Law analysis, the substantive Law of some other jurisdiction would ordinarily or necessarily apply.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -31-

     

    

 

(b)            
THE NEW YORK STATE AND UNITED STATES FEDERAL COURTS SITTING IN NEW YORK COUNTY, NEW YORK, AND ANY OTHER COURT IN ANY OTHER JURISDICTION
IN WHICH AN ACTION IS BROUGHT AGAINST A PARTY TO THIS AGREEMENT BY A THIRD PERSON ASSERTING A CLAIM AGAINST WHICH THE DEFENDANT IS ENTITLED
UNDER THIS AGREEMENT TO BE INDEMNIFIED, SHALL HAVE EXCLUSIVE JURISDICTION OVER ALL ACTIONS, SUITS AND PROCEEDINGS ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE DOCUMENTS RELATED HERETO, AND EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS
PROPERTY, TO THE JURISDICTION OF ANY SUCH COURT IN ANY SUCH ACTION OR PROCEEDING OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT. EACH
PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED
IN ANY SUCH NEW YORK STATE OR UNITED STATES FEDERAL COURT OR SUCH OTHER COURT AS IS PROVIDED FOR IN THE PRECEDING SENTENCE AND THAT A
FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT
OR IN ANY OTHER MANNER PROVIDED BY LAW. SERVICE OF ANY PROCESS OR OTHER DOCUMENT BY REGISTERED MAIL OR NATIONALLY RECOGNIZED OVERNIGHT
DELIVERY SERVICE TO THE ADDRESS FOR THE PARTY RECEIVING THAT SERVICE SET OUT IN THIS AGREEMENT, OR SUCH OTHER ADDRESS AS THAT PARTY MAY
SPECIFY IN WRITING TO THE OTHER PARTY FROM TIME TO TIME, SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY SUCH ACTION, SUIT OR PROCEEDING
IN ANY SUCH COURT.

 

(c)           
EACH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT THAT IT MAY LEGALLY AND EFFECTIVELY DO SO, ANY OBJECTION THAT
IT MAY HAVE OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR
THE DOCUMENTS RELATED HERETO IN ANY NEW YORK STATE OR UNITED STATES FEDERAL COURT SITTING IN NEW YORK COUNTY, NEW YORK OR SUCH OTHER
COURT AS IS PROVIDED FOR IN THE IMMEDIATELY PRECEDING PARAGRAPH. EACH PARTY IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW,
THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF ANY SUCH ACTION OR PROCEEDING IN ANY SUCH COURT.

 

(d)           BECAUSE
DISPUTES ARISING IN CONNECTION WITH COMPLEX BUSINESS TRANSACTIONS ARE MOST QUICKLY AND ECONOMICALLY RESOLVED BY AN EXPERIENCED AND EXPERT
PERSON AND THE PARTIES WANT APPLICABLE LAWS TO APPLY (RATHER THAN ARBITRATION RULES), THE PARTIES DESIRE THAT THEIR DISPUTES BE RESOLVED
BY A JUDGE APPLYING THOSE APPLICABLE LAWS. ACCORDINGLY, TO ACHIEVE THE BEST COMBINATION OF THE BENEFITS OF THE JUDICIAL SYSTEM, EACH
PARTY HERETO IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BASED UPON OR ARISING OUT OF THIS AGREEMENT
OR ANY RELATED DOCUMENT OR ANY DEALINGS BETWEEN THE PARTIES HERETO RELATING TO THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS
WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER
OF THIS TRANSACTION, INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. EACH
PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER
WITH ITS RESPECTIVE LEGAL COUNSEL, AND KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH THAT LEGAL
COUNSEL. IN THE EVENT OF LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

    -32-

     

    

 

 

 

12.8       Specific
Performance.

 

Irreparable
damage would occur if any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. Accordingly, the Parties shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to
enforce specifically the terms and provisions of this Agreement, without bond or other security being required, this being in addition
to any other remedy to which they are entitled at law or in equity.

 

12.9       Interpretation;
Construction.

 

(a)          
 “Agreement” means this agreement together with all schedules and exhibits hereto, as the same may from time to time
be amended, modified, supplemented or restated in accordance with the terms hereof. The use in this Agreement of the term “including”
or “include” means “including, without limitation” or “include, without limitation.”
The words “herein,” “hereof,” “hereunder,” “hereby,” “hereto,”
 “hereinafter,” and other words of similar import refer to this Agreement as a whole, including the schedules and exhibits,
as the same may from time to time be amended, modified, supplemented or restated, and not to any particular article, section, subsection,
paragraph, subparagraph or clause contained in this Agreement. All references to articles, sections, subsections, clauses, paragraphs,
schedules and exhibits mean those provisions of this Agreement and the schedules and exhibits attached to this Agreement, except where
otherwise stated. The title of and the article, section and paragraph headings in this Agreement are for convenience of reference only
and shall not govern or affect the interpretation of any of the terms or provisions of this Agreement. The use herein of the masculine,
feminine or neuter forms shall also denote the other forms, as in each case the context may require.

 

(b)           
Where specific language is used to clarify by example a general statement contained herein, that specific language shall not be deemed
to modify, limit or restrict in any manner the construction of the general statement to which it relates. The language used in this Agreement
has been chosen by the Parties to express their mutual intent, and no rule of strict construction shall be applied against any party.
Accounting terms used but not otherwise defined herein shall have the meanings given to them under GAAP. Unless expressly provided otherwise,
the measure of a period of one month or year for purposes of this Agreement shall be that date of the following month or year corresponding
to the starting date, provided that if no corresponding date exists, the measure shall be that date of the following month or year corresponding
to the next day following the starting date. For example, one month following February 18 is March 18, and one month following March
31 is May 1.

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    -33-

     

    

 

12.10     
Incorporation of Exhibits, Schedules and Annexes.

 

The
Exhibits, Schedules and Annexes identified in this Agreement are incorporated herein by reference and made a part hereof.

 

12.11     Independence
of Covenants and Representations and Warranties.

 

All
covenants hereunder shall be given independent effect so that if a certain action or condition constitutes a default under a certain
covenant, the fact that that action or condition is permitted by another covenant shall not affect the occurrence of that default, unless
expressly permitted under an exception to that initial covenant. In addition, all representations and warranties hereunder shall be given
independent effect so that if a particular representation or warranty proves to be incorrect or is breached, the fact that another representation
or warranty concerning the same or similar subject matter is correct or is not breached shall not affect the incorrectness of or a breach
of a representation and warranty hereunder.

 

12.12     Severability.

 

The
Parties want the provisions of this Agreement be enforced to the fullest extent permissible under the Law and public policies applied
in each jurisdiction in which enforcement is sought. Accordingly, if any provision of this Agreement would be held in any jurisdiction
to be invalid, prohibited or unenforceable for any reason, that provision, as to that jurisdiction, shall be ineffective, without invalidating
the remaining provisions of this Agreement or affecting the validity or enforceability of that provision in any other jurisdiction. Notwithstanding
the foregoing, if that provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in that jurisdiction,
it shall, as to that jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting
the validity or enforceability of that provision in any other jurisdiction.

 

12.13     Counterparts;
Electronic Signatures.

 

This
Agreement may be executed in 2 or more counterparts, each of which shall be deemed an original but all of which together shall constitute
one and the same instrument. Electronic counterpart signatures to this Agreement shall be deemed to be original and shall be acceptable
and binding.

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    -34-

     

    

 

12.14     Conflict
Waiver.

 

Following
consummation of the Contemplated Transactions, Carter Ledyard & Milburn LLP (including John M. Griem, Jr.) (“CLM”)
may serve as counsel to Purchaser or its Affiliates, notwithstanding CLM’s representation of Harris FRC in connection with matters
relating to the Contemplated Transactions or any continued representation by CLM of Harris FRC following the Closing, including in the
event of a dispute between the Parties following the Closing. Each of the Parties consents to such representation by CLM of Purchaser
or its Affiliates and waives any conflict of interest arising therefrom.

 

*       *
        *

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    -35-

     

    

 

IN WITNESS WHEREOF, each
of the undersigned has executed this Agreement as of the date first written above.

 

	 	PURCHASER:
	 	 	 
	 	HARRIS FRC ACQUISITION, LP
	 	By:	Harris FRC Acquisition GP, LLC, its General Partner
	 	 	 
	 	By:	/s/ Clarke
    B. Futch
	 	Name:	Clarke B. Futch
	 	Title: 	Managing Partner
	 	 	 
	 	HARRIS FRC:
	 	 	 
	 	HARRIS FRC CORPORATION
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

[Signature Page to Asset
Purchase Agreement]

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

IN WITNESS WHEREOF, each
of the undersigned has executed this Agreement as of the date first written above.

 

	 	PURCHASER:
	 	 	 
	 	HARRIS FRC ACQUISITION, LP
	 	By:	Harris FRC Acquisition GP, LLC, its General Partner
	 	 	 
	 	By:	
	 	Name:	
	 	Title: 	
	 	 	 
	 	HARRIS FRC:
	 	 	 
	 	HARRIS FRC CORPORATION
	 	 	 
	 	By:	/s/ Mary Ellen Harris
	 	Name:	Mary Ellen Harris
	 	Title:	President

 

[Signature Page to Asset
Purchase Agreement]

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

ANNEX I

 

CERTAIN DEFINITIONS

 

“Affiliate”
means, with respect to any Person (i) a director, officer or 5% or greater shareholder of that Person, (ii) a spouse, parent, sibling
or descendant of that Person (or spouse, parent, sibling or descendant of any director or executive officer of that Person), and (iii)
any other Person that, directly or indirectly through one or more intermediaries, Controls, or is Controlled by, or is under common Control
with, that Person.

 

“Another
Transaction” means the sale of any Purchased Assets or other material assets of Harris FRC or the sale or issuance, directly
or indirectly by merger, consolidation or otherwise, of the majority of the outstanding common stock of Harris FRC.

 

“Business”
business of maintaining and protecting the Transferred Intellectual Property and other rights relating to the Product, collecting distributions
and royalties relating to sales of the Product and complying with and enforcing its rights under the Assigned Contracts.

 

“Business
Day” means any day that is not a Saturday, Sunday or a day on which banking institutions in New York, New York are not required
to be open.

 

“Code”
means the Internal Revenue Code of 1986, as amended.

 

“Contemplated
Transactions” means the transactions contemplated by this Agreement and the Related Documents.

 

“Contract”
means any agreement, contract, license, lease, commitment, arrangement or understanding, whether written or oral.

 

“Control”
means, with respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management
or policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

“Employee
Benefit Plan” means (i) any tax qualified or non-qualified Employee Pension Benefit Plan (as defined in Section 3(2) of ERISA),
including any Multiemployer Plan or Multiple Employer Plan, (ii) any Employee Welfare Benefit Plan (as defined in Section 3(1) of ERISA),
or (iii) any employee benefit, welfare benefit, fringe benefit, compensation, deferred compensation, incentive, profit sharing, bonus,
disability, medical, hospitalization, dental, life or other insurance, tuition, company car, club dues, sick leave, maternity, paternity
or family leave, severance, change of control, parachute, stock option, stock purchase or other plan, program or arrangement, whether
oral or written, whether or not subject to ERISA and whether or not funded.

 

“Encumbrances”
means any security interests, mortgages, deeds of trust, liens, pledges, charges, claims, easements, reservations, restrictions, clouds,
equities, rights of way, options, rights of first refusal, grants of power to confess judgment, conditional sales and title retention
agreements (including any lease in the nature thereof) and all other encumbrances, whether or not relating to the extension of credit
or the borrowing of money.

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    Annex I-1

     

    

 

 

“Environmental,
Health and Safety Laws” means all Laws, Permits and Contracts with Governmental Entities relating to or addressing pollution
or protection of the environment or natural resources, releases of Hazardous Materials, public health and safety or employee health and
safety, including the Solid Waste Disposal Act, as amended, 42 U.S.C. §6901, et seq., the Clean Air Act, as amended, 42 U.S.C.
 §7401 et seq., the Federal Water Pollution Control Act, as amended, 33 U.S.C. §1251 et seq., the Emergency Planning
and Community Right-to-Know Act, as amended, 42 U.S.C. §11001 et seq., the Comprehensive Environmental Response, Compensation,
and Liability Act, as amended, 42 U.S.C. §9601 et seq., the Hazardous Materials Transportation Uniform Safety Act, as amended,
49 U.S.C. §1804 et seq., the Occupational Safety and Health Act of 1970, as amended, the regulations promulgated thereunder,
and any similar Laws and other requirements having the force or effect of Law, and all Orders issued or promulgated thereunder, and all
related common law theories, provided, however, that Environmental, Health and Safety Laws shall not include the Food,
Drug and Cosmetic Act, 21 U.S.C. §321 et. seq. or any Laws, rules and regulations administered or issued by the FDA.

 

“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended.

 

“ERISA
Affiliate” means any Person that, together with Harris FRC, is or was at any time treated as a single employer under Section
414 of the Code or Section 4001 of ERISA and any general partnership of which the Harris FRC is or has been a general partner.

 

“Escrow
Amount” means [*].

 

“Escrow
Agent” means Citizens Bank, National Association.

 

“Escrow
Agreement” means the Escrow Agreement by and among Harris FRC, Purchaser and Escrow Agent.

 

“Expense
Reimbursement Amount” means an amount equal to Purchaser’s documented out-of-pocket legal, accounting and due diligence
fees, costs and expenses payable to third parties in connection with this Agreement and the Contemplated Transactions up to a maximum
amount of [*].

 

“FDA”
means the U.S. Food and Drug Administration.

 

“Fraud”
means a claim for common law fraud with a specific intent to deceive based on a representation contained in this Agreement that meets
the following criteria: (a) at the time that representation was made, (i) that representation was materially inaccurate, (ii) the party
making that representation had actual knowledge of the material inaccuracy of that representation, (iii) the party making that representation
had the specific intent to deceive the other party, and (b) the other party acted in reliance on that inaccurate representation and suffered
financial injury or Loss as a result of that material inaccuracy.

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    Annex I-2

     

    

 

“Fundamental
Documents” means the documents by which any Person (other than an individual) establishes its legal existence or which govern
its internal affairs. For example, the “Fundamental Documents” of a corporation are its certificate of incorporation
and by-laws.

 

“Fundamental
Representations” means the representations and warranties of Harris FRC set out in Sections 5.1, 5.2, 5.3,
5.8 and 5.9.

 

“GAAP”
means United States generally accepted accounting principles as consistently applied by Purchaser.

 

“Governmental
Entity” means any federal, state, local or foreign government or quasi-governmental or regulatory body thereof, or any political
subdivision, court, tribunal, arbitral body (or any department, bureau or division thereof), administrative agency, commission or department
or other governmental authority or instrumentality.

 

“Harris
FRC Indemnified Persons” means Harris FRC and its Affiliates, successors and assigns and the officers, directors and employees
of each of the foregoing.

 

“Harris
FRC Indemnifying Persons” means Harris FRC and its successors and assigns.

 

“Harris
FRC Losses” means any and all Losses sustained, suffered or incurred by any Harris FRC Indemnified Person.

 

“Hazardous
Materials” means any hazardous or toxic chemicals, materials or substances, pollutants, contaminants or crude oil or any fraction
thereof (including as those terms are defined under any Environmental, Health and Safety Law).

 

“HSR
Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

 

“Indemnified
Persons” means and includes the Harris FRC Indemnified Persons or the Purchaser Indemnified Persons, as the case may be.

 

“Indemnifying
Persons” means and includes the Harris FRC Indemnifying Persons or the Purchaser Indemnifying Persons, as the case may be.

 

“Intellectual
Property Rights” means all intellectual property rights including all Patents, Trademarks, Trade Names, domain names, websites,
internet addresses and applications for any of the foregoing, copyrights, copyright rights, Know-How, computer software, confidential
information, franchises, licenses, inventions, marketing materials and other intellectual property, and all documentation and media constituting,
describing or relating to the foregoing, including software, manuals, memoranda and records of a Person.

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    Annex I-3

     

    

 

“Know-How”
means all know-how, technology, techniques, processes, methods and other trade secrets and confidential information, including invention
records, research records and reports, development reports, experimental and other engineering reports, formulae, business methods, product
designs, specifications, quality control procedures, gauging and measuring procedures, and manufacturing, engineering and other drawings,
photographs, data and documentation.

 

“Knowledge”
of any Person means the actual knowledge of that Person after due inquiry. When used in the case of Harris FRC, the term “Knowledge”
means the Knowledge of Mary Ellen Harris, Paul M. Petigrow and Charles Grinnell. When used in the case of Purchaser, the term “Knowledge”
means the actual knowledge of Clarke B. Futch and Anthony G. Rapsomanikis.

 

“Law”
means any law (including common law), statute, constitution, treaty, ordinance, code, rule, official administrative pronouncement, directive,
regulation, guideline or Order of any Governmental Entity.

 

“Liability”
means any liability, commitment or obligation of any nature whatsoever, whether known or unknown, asserted or unasserted, absolute or
contingent, accrued or unaccrued, liquidated or unliquidated and whether due or to become due, regardless of when asserted.

 

“Litigation
Expense” means any expenses incurred in connection with investigating, defending or asserting any claim, legal or administrative
action, suit or Proceeding incident to any matter indemnified against under Article IX, including court filing fees, court costs,
arbitration fees or costs, witness fees and fees and disbursements of legal counsel, investigators, expert witnesses, accountants and
other professionals.

 

“Losses”
means any and all losses, claims, shortages, damages, liabilities, expenses (including reasonable attorneys’ and accountants’
and other professionals’ fees and Litigation Expenses), assessments, and Taxes arising from or in connection with any matter that
is the subject of indemnification under Article IX net of any amounts recovered by the Indemnified Persons under insurance policies
with respect to that Loss.

  

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    Annex I-4

     

    

 

“Material
Adverse Change” means any event, occurrence, fact, condition or change that is, individually or in the aggregate with all other
events, occurrences, facts, conditions or changes, materially adverse to the Business, results of operations, financial condition or
assets of Harris FRC (or other Person, as applicable), taken as a whole, except that none of the following events, occurrences,
facts, conditions or changes shall be deemed to constitute, or contribute to, a “Material Adverse Change”: (a) any
event, occurrence, fact, condition or change, directly or indirectly, arising out of or attributable to: (i) general economic or political
conditions; (ii) conditions generally affecting the industries related to the Purchased Assets; (iii) any changes in financial, banking
or securities markets in general, including any disruption thereof and any decline in the price of any security or any market index or
any change in prevailing interest rates; (iv) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation
or worsening thereof; (v) any action required or permitted to be taken by this Agreement or any action taken (or omitted to be taken)
with the written consent of or at the written request of Purchaser; (vi) any matter of which Purchaser has Knowledge on the date of this
Agreement; (vii) any changes in applicable Laws or accounting rules (including GAAP) or the enforcement, implementation or interpretation
thereof; (viii) the announcement, pendency or completion of the transactions contemplated by this Agreement; (ix) any natural or man-made
disaster or acts of God; or (b) any failure by the Harris FRC to meet any internal or published projections, forecasts or revenue or
earnings predictions (but the underlying causes of those failures (subject to the other provisions of this definition) shall not be excluded).

 

“Orders”
means judgments, writs, decrees, compliance agreements, injunctions or orders of any Governmental Entity or arbitrator.

 

“Patents”
means all pending, abandoned, expired, completed and issued U.S. and foreign patents and applications therefor, including all reissues,
re-examinations, divisions, continuations, continuations-in-part and extensions thereof, foreign equivalents thereto and provisional
and non-provisional applications, including Patent Cooperation Treaty (PCT) and regional patent applications, and all patents issued
on those applications.

 

“Permits”
means all permits, licenses, authorizations, licenses, registrations, franchises, approvals, certificates, variances and similar rights
obtained, or required to be obtained, from Governmental Entities.

 

“Permitted
Encumbrances” means (i) Encumbrances for Taxes not yet due and payable and (ii) mechanic’s, materialman’s, supplier’s,
vendor’s or similar liens arising in the ordinary course of business securing amounts that are not delinquent.

 

“Person”
shall be construed broadly and shall include an individual, a partnership, a corporation, a limited liability company, an association,
a joint stock company, a trust, a joint venture, an unincorporated organization or another entity including a Governmental Entity.

 

“Proceedings”
means actions, suits, claims, litigations, hearings, complaints, grievances, inquiries, audits, examinations, investigations or legal
or administrative or arbitration proceedings.

 

“Purchaser
Indemnified Persons” means Purchaser, its Affiliates, successors and assigns, and the Representatives of each of the foregoing.

 

“Purchaser
Indemnifying Persons” means Purchaser and its successors and assigns.

 

“Purchaser
Losses” means any and all Losses sustained, suffered or incurred by any Purchaser Indemnified Person.

 

[*] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    Annex I-5

     

    

 

 

“Representatives”
means officers, directors, employees, agents, attorneys, accountants and financial advisors of Purchaser or Harris FRC, as the case may
be.

 

“Requisite
Shareholder Approval” means the approval and authorization of this Agreement and the Contemplated Transactions by the requisite
shareholders of Harris FRC in accordance with the Fundamental Documents of Harris FRC and applicable Law.

 

“Shareholder
Claims” means any and all Proceedings brought against Harris FRC or its Affiliates (or the Purchaser or its Affiliates) by
any of its current or former equity holders (whether actual or purported) or any of their Affiliates, or any other Person seeking to
assert, or based upon, ownership or rights to ownership of, or to compensation with respect to, or arising under, any equity securities
of Harris FRC, the Business or the Purchased Assets, whether prior to or following the date of this Agreement or the Closing.

 

“Tax”
or “Taxes” means (i) all income taxes (including any tax on or based upon net income, gross income, income as specially
defined, earnings, profits or selected items of income, earnings or profits) and all gross receipts, escheat, unclaimed property, estimated,
consumption, value added, documentary, transfer, capital, goods and services, business, sales, use, ad valorem, transfer, franchise,
license, withholding (including backup withholding), payroll, employment, excise, environmental (including taxes under Code Section 59A),
social security, severance, stamp, occupation, premium, property or windfall profits taxes, alternative or add-on minimum taxes, customs
duties and other taxes, fees, assessments or charges of any kind whatsoever, together with all interest and penalties, additions to tax
and other additional amounts imposed by any Taxing Authority (domestic or foreign) and (ii) any liability for the payment of any amount
of the type described in clause (i) above as a result of (A) being a “transferee” (within the meaning of Section 6901
of the Code or any other applicable Law) or successor of another Person, (B) being a member of an affiliated, combined, consolidated
unitary or similar group or (C) a contractual arrangement or otherwise.

 

“Tax Return”
means any return, declaration, report, claim for refund, or information return or other document or statement filed or required to be
filed with any Taxing Authority relating to Taxes, including any schedule, annex, supplement or attachment thereto, and including any
amendment of any of the foregoing.

 

“Taxing
Authority” means any Governmental Entity that has the authority to determine the amount of or collect any Taxes.

 

“Trademarks”
means all pending, expired, abandoned, registered, unregistered, and common law U.S. and foreign trademark applications and trademarks,
service mark applications and service marks, designs, logos, and trade dress, including the goodwill related to the foregoing, and all
federal and state registrations thereof, and all trademarks and service marks issued on those applications.

 

“Trade Names”
means (i) names, (ii) brand names, (iii) business names and (iv) logos and all other names and slogans.

 

[*] = Certain confidential information
contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant
to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

    Annex
                                            I-6 

     

    

 

SCHEDULE 1.1(F)

 

LITIGATION AGREEMENTS

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 1.1(G)

 

ASSIGNED TRADEMARKS

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 3.2

 

REVENUE BY COUNTRY

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 5.1

Foreign Qualification

 

New Jersey, state of incorporation.

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 5.2(c)

Harris FRC Authority;
Noncontravention; Consents

 

 The Contemplated Transactions must be approved by the board of directors
and a majority of the shareholders of Harris FRC.

 

Second Amended and Restated License Agreement, dated December 17, 2010, between Harris
FRC and Research Corporation Technologies, Inc.

 

•      Written
notice must be given to RCT prior to assignment (Section 7.18).

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.2(D)

 

CAPITALIZATION

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.4(A)

 

INTELLECTUAL PROPERTY
MATTERS

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 5.4(b)

Intellectual Property
Protections

 

See Schedule 1.1(g).

 

Harris FRC is periodically notified by UCB of necessary renewal filings related to the Transferred Intellectual Property
and executes necessary documentation as requested. UCB is responsible for the registration, maintenance and renewal of the Assigned Trademarks.

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 5.5(a)

Agreements

 

None.

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.5(B)

 

NO DEFAULTS

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.5(C)

 

ROYALTIES

 

[*] = Certain confidential information contained
in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.5(D)

 

CORRESPONDENCE, REPORTS,
NOTICES, ETC.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.5(E)

 

ROYALTIES, ETC., RECEIVED
AND PAID

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.6

 

LITIGATION, ETC.

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 5.8

Taxes.

 

None.

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

Section 5.9

Brokers.

 

Harris FRC has engaged Imperial Capital, LLC as the exclusive financial adviser to Harris FRC in connection with the Contemplated Transactions.

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 5.11

Absence of Changes.

 

See Schedule 5.9. At Harris FRC’s request, Imperial Capital, LLC conducted an auction process for the Business, which has culminated
in the Contemplated Transactions.

 

In response to the COVID-19 pandemic, New Jersey Governor Philip D. Murphy has enacted executive orders
directing residents to stay at home and limiting the operation of nonessential business. To comply with the executive orders and help
ensure the health and safety of its employees, beginning in March 2020, Harris FRC has caused its employees to work from home. Remote
working is a departure from Harris FRC’s past practice and has mainly affected administrative work requiring a physical presence
in the Harris FRC office.

 

The COVID-19 pandemic appears to have affected prescribing and dispensing patterns for VIMPAT, including an
acceleration of VIMPAT prescribing and dispensing around the end of Q1 2020 and a slowdown in VIMPAT prescribing and dispensing around
the beginning of Q2 2020. Disruptions to the health care system as a result of government restrictions and an overload of COVID-19 patients
appear to have caused a slowdown in new patients starting on VIMPAT, perhaps as a result of difficulties in completing the required diagnostic
work. Increased unemployment as a result of COVID-19-related economic disruptions, which can result in loss of health insurance and economic
constraints for current and prospective VIMPAT patients, may adversely affect VIMPAT sales.

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

SCHEDULE 5.14(A)

 

BUSINESS EMPLOYEES

 

[*] = Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 5.14(b)

Employee Benefit Plans.

  

•      Health
Insurance: Horizon Direct Access Platinum Plan

 

•      Dental
and Vision Insurance: Guardian DentalGuard/Vision

 

•      Harris
FRC Corporation 401K Plan

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

     

     

    

 

Schedule 6.2

Purchaser Authority;
Noncontravention; Consents.

 

None.

 

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]